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The physiological mechanisms involved in regulating extracellular osmolality are critical to 
understand how mammals cope with dehydration and water deprivation. Osmoregulation is a 
crucial homeostatic process in mammals that functions to maintain a physiological setpoint of 
extracellular osmolality. Magnocellular neurosecretory cells (MNCs) of the hypothalamus sense 
changes in external osmolality and transduce changes in cell volume into depolarizing currents 
and action potential (AP) firing, leading to the release of the hormone vasopressin (VP), which 
prevents water loss from the kidneys. MNCs lack the normal volume regulatory mechanisms 
present in other cells, and possess mechanosensitive channels called ∆N-TRPV1 that enable cation 
influx and MNC plasma membrane depolarization upon activation by cell shrinkage that involves 
a Ca2+-dependent isoform of the enzyme phospholipase C (PLC) called PLC𝛿1. Sustained 
exposure (i.e., longer than 1 hour) to high osmolality causes structural and functional adaptations 
in MNCs, like somatic hypertrophy, channel translocation, and changes in gene expression. We 
propose a potential mechanism for MNC hypertrophy and for osmotically induced ∆N-TRPV1 
translocation in MNCs that may provide insight into the underlying mechanisms of long-term 
MNC osmoregulation. Isolated MNCs treated with hyperosmotic saline for 1 hour elicited somatic 
hypertrophy as well as a significant increase in the number of ∆N-TRPV1 channels present on the 
plasma membrane. Both the increase in plasma membrane ∆N-TRPV1 and MNC hypertrophy 
were shown to be reversible once isolated MNCs were returned to isosmotic solution. The increase 
in plasma membrane ∆N-TRPV1 and hypertrophy were observed to be PLC- and protein kinase C 
(PKC)-dependent, and both required SNARE-mediated exocytosis and movement of vesicles from 
the Golgi, as inhibitors of PLC, PKC, the SNARE complex, and the Golgi all prevented the 
osmotically induced increase in plasma membrane ∆N-TRPV1 as well as hypertrophy. It was also 
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observed that the retrieval of ∆N-TRPV1 from the plasma membrane as well as the recovery from 
hypertrophy require dynamin-mediated endocytosis, as using an inhibitor of dynamin prevented 
the retrieval of ∆N-TRPV1 from the plasma membrane and the recovery from hypertrophy. 
Finally, we report that mice that lack PLC𝛿1 fail to elicit an increase in plasma membrane ∆N-
TRPV1 or hypertrophy in response to high external osmolality, suggesting that this enzyme is 
necessary for these processes. This project will help to elucidate the potential mechanisms 
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CHAPTER 1: INTRODUCTION 
 
1.1 Osmolality, osmolarity, and osmoregulation 
 
Solutions comprised of solute and solvent possess physical properties that depend on the relative 
amounts of each, which are referred to as colligative properties (Pinarbasi et al., 2009). These 
properties include freezing point, boiling point, vapour pressure, and osmotic pressure (Voet et al., 
2000). In cellular physiology the most important colligative property is osmotic pressure (Sanger 
et al., 2001), which is defined as, “the minimum pressure that must be applied to a solution in order 
to prevent inward flow of solvent across a semi-permeable membrane” (Voet et al., 2000). When 
two solutions comprised of different solute concentrations are separated by a semi-permeable 
membrane, water will move across the membrane from the solution with a lower solute 
concentration to the solution with a higher solute concentration through passive diffusion, which 
is known as osmosis (Voet et al., 2000). In living organisms with a selectively permeable cell 
membrane, osmosis occurs between the extracellular fluid (ECF) and intracellular fluid (ICF). In 
multicellular organisms, the relevant solutes in the ECF and ICF that dictate osmosis are mainly 
electrolytes (e.g., ions), but organic molecules (e.g., proteins, hormones, neurotransmitters) can 
also influence osmosis (Fleischhaur et al., 1995). The ICF is comprised of the cellular cytosol and 
is also known as the fluid of the internal environment of a cell (Luby-Phelps, 1999). The ECF 
consists of both the interstitial fluid (i.e., the fluid in between cells) and the blood plasma (e.g., the 
noncellular component of blood; Gauer et al., 1970). It is critical to maintain fluid and electrolyte 
balance within an organism (Rolls and Phillips, 1990), and the maintenance and regulation of both 
fluid and electrolyte balance are accomplished at the cellular level, as well as the organ level 
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(Sawka and Montain, 2000). The renal system is a chief regulator of fluid and electrolyte balance 
in mammals (Bankir et al., 1989). At the cellular level the plasma membrane is key to this balance, 
which is accomplished by specialized pores and channels in the plasma membrane that allow water 
and ions to passively move between the ICF and ECF (Curran and Solomon, 1957). Osmolality is 
a measurement that calculates the moles of osmolytes (e.g., ions, proteins, or other small organic 
molecules) present per kilogram of solvent and is expressed in the units of osmoles per kilogram 
(osmol kg-1), or more commonly in mammals, in milliosmoles per kilogram (mosmol kg-1). 
Osmolarity is an analogous measurement that is often mistaken for osmolality. Although the two 
terms measure the moles of osmolyte per amount solvent, osmolarity indicates the moles of 
osmolyte per litre of solvent instead of per kilogram of solvent and is expressed using osmoles per 
litre (osmol L-1) or milliosmoles per litre (mosmol L-1; Erstad, 2003). 
 
Some aquatic animals possess the ability to change the osmolality of their internal environment 
based on the osmolality of their external environment through optimized cell volume regulatory 
mechanisms and are therefore termed osmoconformers because of their ability to conform to the 
osmolality of whatever environment they are present in (Bourque, 2008). Mammals, however, 
must regulate the osmolality of their internal environment, and maintain a range of osmolalities 
close to a physiological “setpoint” (usually around 300 mosmol kg-1; Bourque, 2008). Mammals 
are therefore termed osmoregulators for their requirement to constantly regulate their internal 
osmolality (Bourque, 2008). ECF osmolality within a certain range in mammals (usually within 
10 mosmol kg-1) is deemed isosmotic to the animal. ECF osmolality lower than normal is deemed 
hypoosmotic, while ECF osmolality higher than the normal range is deemed hyperosmotic. When 
ECF osmolality changes, water flows through the cell membrane via osmosis, which maintains 
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osmotic equilibrium between the ICF and ECF (Halperin and Skorecki, 1986; Bourque, 2008), 
with the difference in osmolality between the two compartments being the driving force for 
osmotic pressure that enables osmosis to occur (Guyton and Hall, 2006; Boron and Boulpaep, 
2017). In the ECF the most important ion present is sodium (Na+; Terry, 1994) and regulating Na+ 
and water levels is the primary regulatory process mammals utilize to maintain isosmotic ECF 
osmolality (Guyton and Hall, 2006; Bourque, 2008). Na+ regulation occurs through changes in 
Na+ appetite (Weisinger et al., 1983; Blackburn et al., 1993) and changes in the rate of Na+ 
excretion (i.e., natriuresis; Huang et al., 1996). Water levels are regulated through thirst, sweating, 
evaporation, and urine output (Verney, 1947; Zerbe and Robertson, 1983; Fortney et al., 1984; 
Tucker, 1968; Bourque, 2008). Behaviourally, high serum osmolality from dehydration triggers 
thirst in mammals and the desire to drink water to alleviate the osmotic stress on the body (Maresh 
et al., 2001; Smith et al., 2004). Urine output is also decreased under hyperosmolar conditions 
(Bourque, 2008). In situations of over-hydration, in which ECF osmolality becomes hypoosmotic, 
thirst and salt appetite are decreased, and urine output is increased to restore the ECF osmolality 
to isosmotic levels (Bourque, 2008). ECF hyperosmolality causes cells to shrink due to water 
moving from ICF to ECF through water pores until osmotic equilibrium is restored, while ECF 
hypoosmolality causes cellular swelling due to water moving into the cell (Lang et al., 1998; Lang, 
2007; Chamberlin and Strange, 1989). Many cells possess cell volume regulatory mechanisms to 
respond to these changes in cell volume. Shrinkage due to hyperosmolality will activate ion 
channels that will move solutes into the cell from the extracellular fluid (ECF) in order to restore 
osmotic balance (Lang 2007; Lang et al., 1998). Among these ion channels are: the NKCC1 
cotransporter, the Na+/H+ antiporter, and the HCO3- /Cl- antiporter (Lang 2007; Grinstein and 
Foskett, 1990). NKCC1 causes the influx of Na+, K+, and 2 Cl-; the Na+/H+ antiporter brings Na+ 
 4 
into the cell while expelling H+, and the HCO3-/Cl- exchanger brings Cl- into the cell while 
expelling HCO3- (Lang et al., 1998; Lang 2007; Boron and Boulpaep, 2017). The H+ and HCO3- 
form H2O and CO2 outside the cell, which then passively diffuse into the cell due to the increase 
in ions from the transporters mentioned above (Lang 2007; Boron and Boulpaep, 2017). As the 
ion and water concentrations return to an equilibrium, the cell returns to its original volume. This 
response to cell shrinkage is known as regulatory volume increase (RVI; Lang et al., 1998). The 
opposite occurs in response to hypoosmolality, where cellular swelling inactivates the channels 
that increase their basal activity during RVI and activates K+ and Cl- leak channels as well as a 
K+/Cl- cotransporter in order to expel K+ and Cl- ions into the ECF (Lang et al., 1998; Lang 2007; 
Boron and Boulpaep, 2017). H2O then passively follows the ion flow out of the cell and the cell 
returns to its original volume. The response to cell swelling is also known as regulatory volume 
decrease (RVD; Lang et al., 1998). The maintenance and close regulation of ECF osmolality is 
essential for mammals, especially in the brain, where large changes in cell volume could 
potentially damage the brain parenchyma (Bourque, 2008). The structural integrity and health of 
this tissue is imperative to proper organismal function and survival, and severe damage can lead 




1.2.1 Osmoreceptor function 
 
Osmoregulation is a crucial homeostatic process in mammals that functions to maintain a 
physiological setpoint of serum osmolality (Zerbe and Robertson, 1983). Because mammals are 
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sensitive to changes in ECF osmolality, they must closely regulate their internal environments. 
This is accomplished largely through osmoreceptors, which are unique cells specifically designed 
to detect changes in ECF osmolality and activate mechanisms throughout the body to cope with 
these changes and restore ECF osmolality (Bourque, 2008).  These osmoreceptors are largely 
present in the brain and are the chief regulators of osmotic homeostasis in mammals (Jewell and 
Verney, 1957; Verney, 1947). Many years of research have led to the conclusion that the 
physiological setpoint of ECF osmolality is determined by osmoreceptor electrical activity 
(Bourque, 2008). The resting membrane potential (RMP) of a cell is defined as the electrical 
potential difference across a cell membrane of an excitable cell at rest (Hodgkin and Huxley, 
1952). In osmoreceptors, RMP is influenced by membrane stretch, which can then be transduced 
to changes in ion channel activity, thereby changing the electrical potential difference across a cell 
membrane and therefore the cell’s excitability (Verney, 1947; Hodgkin and Huxley, 1952; 
Bourque, 2008). Changes in ECF osmolality therefore change the excitability of osmoreceptors, 
which then changes their likelihood to fire action potentials (APs; Bourque, 2008).  
 
1.2.2 Anatomy and morphology 
 
Many of the cerebral osmoreceptors are located in the organum vasculosum of the lamina 
terminalis (OVLT; Thrasher et al., 1982) and in the subfornical organ (SFO; Anderson et al., 2000), 
which are anatomically located, respectively, on the ventral and dorsal surfaces of the third 
ventricle (Morita et al., 2004; Egan et al., 2003). These primary osmoreceptors sense changes in 
extracellular fluid (ECF) osmolality and adjust their firing rate (Bourque and Oliet, 1997; Bourque 
et al., 1994). These primary osmoreceptors project to other osmoreceptors through the median 
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preoptic nucleus (MnPO) to neurons located in the supraoptic nucleus (SON; Oliet and Bourque, 
1992; Oliet and Bourque, 1993; Bourque et al., 1994) and paraventricular nucleus (PVN; Qiu et 
al., 2004) and release glutamate (GLUT) to enhance the activity of the neurons in these nuclei. The 
SON and PVN possess a specialized type of osmoreceptor known as a magnocellular 
neurosecretory cell (MNC; Oliet and Bourque, 1992; Qiu et al., 2004). MNCs in the SON are 
mostly surrounded by other MNCs, but astrocytes (Tweedle and Hatton, 1977; Theodosis and 
Poulain, 1984) and some interneurons (Hatton, 1990) are also present. These neurons also possess 
a singular axon (Brownstein et al., 1980) and between 1 and 3 dendrites (Stern and Armstrong, 
1998). The dendrites primarily project to the surrounding glia (Armstrong et al., 1982), while MNC 
axons project mostly to the posterior pituitary (PP; Brownstein et al., 1980). MNCs located in the 
SON and PVN have 2 subtypes: vasopressin (VP)- synthesizing, and oxytocin (OT)- synthesizing 
(Swaab et al., 1975; Sofroniew, 1982; Bicknell, 1988). There is also some evidence for the 
presence of peripheral osmoreceptors located in the stomach (Carlson et al., 1997) and the liver 
(Baertschi and Vallet, 1981), but the focus of this thesis will be on central osmoreception. 
 
1.2.3 Neurohypophysial hormones and hormonal release 
 
VP is a neuroendocrine hormone synthesized in MNC cell bodies that is packaged into synaptic 
vesicles and then moved down a singular axon through the median eminence where it is then 
released from axon terminals located in the PP (Brownstein et al., 1980; Bicknell, 1988). Hormonal 
release from axon terminals occurs when an AP reaches a terminal, depolarizes the surrounding 
membrane, and activates voltage-gated Ca2+ channels (VGCCs; Hatton, 1990; Armstrong, 1995), 
which leads to Ca2+ influx and subsequent exocytosis of vesicles containing VP (or OT) into the 
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general circulation through the blood plexus located in the PP (Hatton, 1990; Armstrong, 1995). 
VP release from MNCs can also occur without AP firing through a phenomenon known as quantal 
release (Roper et al., 2004), but the majority of AP release requires APs. Once in the general 
circulation, VP travels to the kidneys and binds to vasopressin-2 receptors (VR2) located on 
epithelial cells of the cortical collecting duct (CCD) in the distal nephron (Agre, 2006: Petersen, 
2006: Ball, 2007). The binding of VP to VR2 promotes water reabsorption through insertion of 
specialized water channels called aquaporin-2 (AQP2) into the apical membrane of CCD epithelial 
cells via cyclic adenosine monophosphate (cAMP)-dependent translocation (Knepper et al., 2015; 
Agre, 2006: Peterson, 2006: Ball, 2007). The basolateral membrane of the CCD epithelial cells 
also possesses AQP3 and AQP4 which also aids in water reabsorption (Agre, 2006: Peterson, 2006: 
Ball, 2007). In the brain, it has been shown that VP also helps maintain cellular water and salt 
balance through AQP modulation on astrocyte membranes (Niermann et al., 2001). MNCs can 
also release VP from dendrites to surrounding astrocytes, which has been thought to play a role in 
regulating MNC function (Ludwig, 1998). 
 
OT is a neuroendocrine hormone that is largely involved in promoting childbirth and lactation in 
females (Moon and Turner, 1959; Guyton and Hall, 2006), and sperm motility and testosterone 
production in males (Studdard et al., 2002; Gupta et al., 2008), but is also involved in inhibiting 
salt appetite (Blackburn et al., 1993; Blackburn et al., 1995). In the brain, OT functions to influence 
a variety of behaviours, including sexual arousal (Murphy et al., 1987; Blaicher et al., 1999) and 
personal attachment (Fineberg and Ross, 2017). OT also possesses a natriuretic role in rodents 
(Verbalis et al., 1991).  OT-MNCs have also been shown to be osmosensitive and respond to 
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changes in cell volume (Wakerly et al., 1978). OT release from MNCs increases with progressive 
dehydration (Wakerly et al., 1978; Marzban et al., 1992). 
 
MNCs at rest fire 1-3 APs per second (Poulain and Wakerly, 1982), which corresponds to a small 
amount of hormone being released from the axon terminal. However, hyperosmotic stimulation 
can rapidly enhance AP firing from MNCs (Poulain and Wakerly, 1982), which enhances 
subsequent hormone release. At a certain level of hyperosmotic stimulation, MNCs switch to a 
phasic firing pattern, which is a specific type of burst firing in which a high frequency of APs is 
fired followed by a period of rest (Dutton and Dyball, 1979; Bicknell and Leng, 1981). This firing 
pattern has shown to be the most effective for rapid hormone release from axon terminals in both 
VP- and OT-MNCs (Dutton and Dyball, 1979; Bicknell and Leng, 1981; Andrew and Dudek, 
1984). These observations showed that the firing pattern of MNCs can change to meet the demand 
for hormone release (Bicknell, 1988). OT-MNCs also display shorter and faster phasic firing 
patterns than VP-MNCs (Wakerly et al., 1978). 
 
1.2.4 MNC activity 
 
MNCs are specialized neurons in the SON and PVN that detect changes in external osmolality 
(Bourque et al., 2007; Bourque, 2008). Changes in external osmolality change MNC membrane 
potential, thereby affecting the ability to fire APs and therefore also affecting VP and OT release 
(Oliet and Bourque, 1992; Bourque, 2008; Bicknell, 1988). MNCs transduce decreases in cell 
volume caused by increases in external osmolality into depolarizing currents via mechanosensitive 
channels (Oliet and Bourque, 1993), which increases the likelihood of MNC action potential (AP) 
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firing in response to excitatory inputs coming from osmoreceptors in the OVLT and SFO (Bourque 
and Oliet, 1997). Increases in osmolality as little as 3 mosmol kg-1 can significantly enhance MNC 
AP firing (Poulain and Wakerly, 1982; Bourque and Oliet, 1997). This can then lead to the 
downstream release of VP into the PP and therefore enhance water reabsorption at the kidneys to 
prevent further increases in osmolality from occurring (Robertson et al., 1976). The 
mechanosensitive channels that mediate the transduction of cell volume changes into depolarizing 
currents are inactivated by increases in membrane tension (i.e., membrane expansion; Oliet and 
Bourque, 1993; Bourque, 2008). Under hypoosmotic conditions MNCs swell and the 
mechanosensitive channels close, which leads to a decrease in depolarizing current, and under 
hyperosmotic conditions MNCs shrink and the mechanosensitive channels open, leading to an 
increase in depolarizing current (Oliet and Bourque, 1993; Bourque, 2008). Depriving rats of water 
for 24 hours also enhances L-type Ca2+ current in MNCs (Zhang et al., 2007a). ∆N-TRPV1 
channels in MNCs interact with the cytoskeleton, and it is thought that the force exerted onto the 
channels by the cytoskeleton in response to changes in external osmolality triggers the opening or 
closing of the channel. The mechanosensitivity of MNCs involves actin filaments as well as 
microtubules (MTs; Zhang et al., 2007b; Prager-Khoutorsky et al., 2014). These molecules have 
been hypothesized to also be involved in regulating mechanosensitive ion channel activity in 
MNCs during osmoregulation (Prager-Khoutorsky et al., 2014; Prager-Khoutorsky and Bourque, 






1.2.5 ∆N-TRPV1 in MNCs 
 
The transient receptor potential (TRP) family of channels is a group of non-selective cation 
channels that have multiple subtypes and subfamilies with widespread expression throughout the 
nervous system (Montell, 2001). The TRP vanilloid (TRPV) subfamily are expressed in multiple 
types of excitable cells like neurons (Montell, 2001; Montell, 2005) and are known to be sensitive 
to heat and capsaicin (Caterina et al., 1997). The TRPV1 channel is an important contributor to 
neuronal depolarization as it is a nonselective cation channel (Kedei et al., 2001; Clapham, 2003) 
that is permeable to Ca2+, Na+, and K+. An N-terminal variant of the TRPV1 channel has been 
identified in MNCs and is now known as ∆N-TRPV1 (Sharif-Naeini et al., 2006; Zaelzer et al., 
2015). ∆N-TRPV1 is a mechanosensitive channel, meaning it is stretch-gated and is influenced by 
changes in cell volume (Prager-Khoutorsky et al., 2014; Prager-Khoutorsky and Bourque, 2015). 
∆N-TRPV1 is mechanically linked to the cytoskeleton through connections with MTs (Prager-
Khoutorsky et al., 2014; Prager-Khoutorsky and Bourque, 2015). Disrupting the mechanical 
linkage between MTs and ∆N-TRPV1 prevents increases in MNC firing under osmotic stress 
(Prager-Khoutorsky et al., 2014; Prager-Khoutorsky and Bourque, 2015). Actin also plays a role 
in mediating ∆N-TRPV1 mechanosensitivity (Zhang et al., 2007b; Prager-Khoutorsky and 
Bourque, 2015). Osmotically evoked filamentous actin (F-actin) polymerization enhances the 
mechanical gating of ∆N-TRPV1 (Zhang et al., 2007b), which could possibly occur through 
regulation of mechanical plasma membrane support (Prager-Khoutorsky, 2017). The exact 
mechanism of the actin- ∆N-TRPV1 interaction remains elusive. MNCs express a unique MT 
scaffold that enables them to transduce changes in cell volume into depolarizing currents through 
physical interactions with ∆N-TRPV1 (Prager-Khoutorsky et al., 2014). ∆N-TRPV1 
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mechanosensitivity is also influenced by interactions with subcortical actin (Prager-Khoutorsky 
and Bourque, 2015; Prager-Khoutorsky, 2017). When there is a disruption in the MT scaffold or 
in the subcortical actin that can lead to the dissociation of either MTs or actin, MNCs lose the 
ability to transduce changes in cell volume into depolarizing currents (Prager-Khoutorsky et al., 
2014; Prager-Khoutorsky and Bourque, 2015; Prager-Khoutorsky, 2017). MT dissociation also 
prevents osmotically induced increases in ∆N-TRPV1 current and MNC osmosensory transduction 
from occurring (Prager-Khoutorsky et al., 2014), suggesting that the ∆N-TRPV1-cytoskeleton 
interaction is integral to transducing osmotically evoked changes in MNC cell volume into 
depolarizing currents that can increase the likelihood of AP firing and therefore VP release.  
 
1.3 Osmotic Adaptations 
 
1.3.1 Short-term adaptations 
 
MNCs are able to respond quickly to changes in osmolality and modulate their electrical and 
physiological activity accordingly (Bourque et al., 1994; Zhang and Bourque, 2003; Bourque, 
2008). These changes in osmolality lead to the opening of ion channels, which causes changes in 
cellular conductance (Bourque et al., 2002) Conductance is the ability of a cell to move ions across 
the cell membrane (Baxter and Byrne, 1991). The change in electrical activity is mediated by ∆N-
TRPV1 channels (Zaelzer et al., 2015). All cells rapidly shrink when exposed to hyperosmotic 
solution (Lang et al., 1998). In MNCs the decrease in membrane tension that occurs as a result of 
membrane shrinkage when exposed to hyperosmotic solution activates ∆N-TRPV1 channels and 
promotes cation influx, depolarization, AP firing, and downstream VP release (Bourque, 2008; 
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Zaelzer et al., 2015). The opposite occurs in response to a decrease in external osmolality; MNCs 
swell, membrane tension increases, and ∆N-TRPV1 inactivates, resulting in hyperpolarization, 
decreased AP firing and decreased VP release (Bourque, 2008; Zaelzer et al., 2015). The increase 
in VP release from MNCs in response to high osmolality is a clever mechanism that mammals 
have developed to enhance water reabsorption and prevent further increases in external osmolality 
from occurring (Bourque, 2008). Hyperosmotic or hypoosmotic exposure caused rapid shrinkage 
or swelling, respectively, in both hippocampal neurons and in MNCs (Zhang and Bourque, 2003). 
Cells were exposed to either hyperosmotic or hypoosmotic solution for up to 14 minutes (Zhang 
and Bourque, 2003). MNCs displayed a more dramatic and longer-lasting shrinkage or swelling 
than did hippocampal neurons (Zhang and Bourque, 2003). MNCs remained shrunk or swollen as 
long as the osmotic stressor was present, while hippocampal neurons rapidly returned to close to 
their original volume through RVI and RVD (Zhang and Bourque, 2003). This finding suggested 
that MNCs do not possess the cell volume regulatory processes present in most other cell types 
(e.g., the mechanisms described in section 1.1; Zhang and Bourque, 2003). Because MNCs are 
osmoreceptors and rely on changes in cell volume and membrane tension to transduce changes in 
external osmolality into depolarizing currents, the lack of normal volume regulatory mechanisms 
has been suggested to allow mechanosensitive ∆N-TRPV1 channels to transduce the changes in 
external osmolality into those depolarizing currents in order to enhance AP firing and VP release 






1.3.1.1 Phospholipase C  
 
Phospholipase C (PLC) is a key enzyme involved in multiple intracellular processes in multiple 
cell types (Rhee, 2001). PLC cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 
triphosphate (IP3) and diacylglycerol (DAG; Rhee, 2001). IP3 enhances Ca2+ release from 
intracellular stores like the endoplasmic reticulum (Rhee, 2001). DAG is an important second 
messenger that remains in the cytoplasm and activates the enzyme protein kinase C (PKC; Rhee, 
2001). PKC is a versatile phosphorylating enzyme with a variety of intracellular functions 
including modulating channel translocation and protein expression (Bell, 1986; Premkumar and 
Ahern, 2000; Vellani et al., 2001; Strong et al., 1987). In addition to being a precursor molecule 
for IP3 and DAG, PIP2 is known to be involved in ion channel regulation (Suh and Hille, 2008), 
and to interact with the cytoskeleton (Raucher et al., 2000; Logan and Mandato, 2006).  
 
Many families of PLC exist, but the 3 most well-studied families are PLC𝛽, PLC𝛾, and PLC𝛿, 
which each possess distinct mechanisms of activation and requirements for activation that are 
specific to their function within the cell (Rohacs et al., 2008; Rohacs, 2013). PLC𝛿 is the most 
poorly understood of these isoform families (Rebecchi and Pentyala, 2000), but it is known to 
require an increase in intracellular Ca2+ ([Ca2+]i) for full activation (Allen et al., 1997; Rohacs et 
al., 2008). PLC𝛿 isoforms are the most sensitive to small changes in [Ca2+]i (Allen et al., 1997; 
Rohacs et al., 2008). PLC𝛽 isoforms are activated by interactions with the G𝛽𝛾 or Gq𝛼 subunits 
of G-protein coupled receptors (GPCRs; Rebecchi and Pentyala, 2000; Rohacs et al., 2008). PLC𝛾 
isoforms are activated by adjacent receptor tyrosine kinases (RTKs), which act as receptors for 
hormones like insulin (Rebecchi and Pentyala, 2000; Rohacs et al., 2008). These isoforms are 
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expressed in brain tissue including the SON (Suh et al., 1988; Lee et al., 1999; Suh et al., 2008). 
The PLC𝛿 isoforms are primarily stimulated by intracellular Ca2+ (Essen et al., 1996), and are 
expressed in MNCs (Allen et al., 1997; Fukami et al., 2001; Hazell et al., 2012). PLC𝛿1 and 
PLC𝛿4 isoforms have been identified in MNCs (Hazell et al., 2012; Nakamura and Fukami, 2017). 
PLC𝛿1 is the most Ca2+-sensitive PLC𝛿 isoform (Suh et al., 1988; Lee et al., 1999). The 
physiological role of the PLC𝛿 family is well-understood in other cell types such as keratinocytes 
and cardiac myocytes, but its role in neurons remains poorly understood (Kadamur and Ross, 2013; 
Nakamura and Fukami, 2017).  
 
1.3.1.2 Angiotensin II 
 
Angiotensin II (Ang II) is a peptide hormone that possesses a variety of functions in the body, 
including increasing blood pressure, Na+ reabsorption, and VP release (Fyhrquist et al., 1995; 
Jhamandas et al., 1989; Buggy et al., 1979; Qadri et al., 1993). It is synthesized largely outside the 
brain (Bie et al., 2004), but within brain tissue it is synthesized and released from osmoreceptors 
in the OVLT and SFO and provides excitatory input to MNCs in the SON and PVN (Renaud et 
al., 1983; Jhamandas et al., 1989; Li and Ferguson, 1993). Ang II is released from the OVLT and 
SFO in response to systemic hypovolemia or hypernatremia, both of which involve an increase in 
ECF osmolality (Jhamandas et al., 1989; Li and Ferguson, 1993). Ang II binds to the angiotensin 
type-1 receptor (AT1R) present on MNC cell bodies (Morris et al., 1999) and potentiates MNC 
sensitivity to changes in external osmolality (Chakfe and Bourque, 2000). The modulation of MNC 
mechanosensitivity by Ang II occurs through interactions with PLC and PKC (Zhang et al., 2007b; 
Zhang and Bourque, 2008; Prager-Khoutorsky and Bourque, 2010). Isolated MNCs exposed to 
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Ang II exhibited enhanced cortical F-actin polymerization (Zhang et al., 2007b) and TRPV1 open 
probability (Zhang and Bourque, 2008). These events occur in a PLC-dependent manner in MNCs 
(Zhang et al., 2007b; Zhang and Bourque, 2008; Prager-Khoutorsky and Bourque, 2010). 
 
1.3.2 Long-term adaptations 
 
Mammals are able to adapt to long-term water deprivation and dehydration through behavioural 
mechanisms as well as through neurohormonal mechanisms that involve MNCs (Bourque, 2008). 
This can be examined in vivo by depriving rats of water for periods of days (Modney and Hatton, 
1989; Wakerly et al., 1982). These adaptations can also be studied in vitro by exposing isolated 
MNCs to solutions of varying osmolalities and observing the responses (Shah et al., 2014). MNC 
adaptations are sustained as long as the stressor is present and are reversed when the stressor is 
removed, and involve both structural and functional adaptations (Hatton, 1997), as well as changes 
in gene expression and membrane density of channels and receptors (Shuster et al., 1999; Tanaka 
et al., 1999; Hurbin et al., 2002). 
 
1.3.2.1 Structural adaptations 
 
MNCs in the SON and the surrounding glia undergo structural changes that potentially contribute 
to sustained hormone release during sustained increases in external osmolality (Hatton, 1997). 
Under normal homeostatic conditions about 1% of MNCs in the SON are in direct membranous 
contact with other MNCs (Tweedle and Hatton, 1977; Modney and Hatton, 1989). However, 
during periods of dehydration MNC-MNC contact can increase to about 10% and is reversible 
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with rehydration (Tweedle and Hatton, 1976; Tweedle and Hatton, 1977; Gregory et al., 1980). 
The increase in MNC-MNC contact coincides with increases in the size of the SON under long-
term hyperosmotic stress (Tweedle and Hatton, 1976; Tweedle and Hatton, 1977; Gregory et al., 
1980). Increases in blood osmolality from dehydration cause glial retraction in the SON and PP, 
and MNC somatic hypertrophy (Modney and Hatton, 1989; Marzban et al., 1992). Long-term 
hyperosmotic stress lasting days can lead to glial retraction in the SON and PP as well as 
enlargement of MNCs in the SON (Modney and Hatton, 1989; Marzban et al., 1992). In rats that 
were subjected to a 10-day dehydration period via drinking hyperosmotic water, there was about 
a 170% increase in the size of their SONs compared to hydrated rats (Modney and Hatton, 1989).   
Capacitance represents the capacity of charge separation of a cell and is dependent on the plasma 
membrane surface area (Hille, 2001; Partridge and Partridge, 2003), and can be continually 
measured in cells and is used to understand membrane dynamics under stressors like either 
hypoosmotic or hyperosmotic shock (Rhoades and Bell, 2009; Boron and Boulpaep, 2017). When 
hippocampal neurons were exposed to either a hyperosmotic or hypoosmotic solution, they 
displayed respective increases or decreases in capacitance (Zhang and Bourque, 2003). Exposure 
to hyperosmotic or hypoosmotic stress for 14 minutes did not result in a change in capacitance in 
MNCs (Zhang and Bourque, 2003). However, a 33% increase in membrane capacitance was 
observed in the MNCs of rats that were progressively dehydrated by drinking salt water for 7 days 
(Tanaka et al., 1999). Another study by Shah et al., (2014) found that 90-minute hyperosmotic 
exposure resulted in a 7% increase in MNC capacitance. These studies suggest that acute 
osmotically evoked changes in MNC size are not associated with changes in membrane 
capacitance, but sustained exposure to hyperosmolality can lead to changes in MNC membrane 
capacitance. Another study examined changes in MNC structure under hypoosmotic conditions in 
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rats and found that a 7-day hypoosmotic challenge through pharmacological inhibition of urine 
production led to a 40% decrease in both somatic area and nuclear size (Verbalis and Drutarosky, 
1988; Zhang et al., 2001). These findings examined together suggest that MNCs possess the ability 
to structurally adapt and change their cell size in response to both hyperosmotic and hypoosmotic 
stressors (Hatton, 1997; Zhang et al., 2001; Bourque, 2008). In a study conducted by Beagley and 
Hatton (1992) rats were injected with hyperosmotic saline, and their MNCs were examined 5 hours 
after injection. There was a significant increase in MNC size, suggesting that MNC hypertrophy 
occurs within hours (Beagley and Hatton, 1992). Another study by Shah et al., (2014) observed 
MNC hypertrophy in vitro after 90-minute hyperosmotic stimulation of isolated MNCs, which will 
be discussed in more detail in section 1.5.1. 
 
1.3.2.2 Functional adaptations 
 
MNCs also adapt functionally under osmotic stress through the enhanced membrane density of 
different membrane receptors and ion channels (Glasgow et al., 2000; Burbach et al., 2001; Yue 
et al., 2006; Shuster et al., 1999; Tanaka et al., 1999). The changes in protein density are 
hypothesized to enable MNCs to fire APs more rapidly to sustain a high level of hormonal release 
(e.g., VP) to cope with sustained increases in external osmolality (Glasgow et al., 2000; Burbach 
et al., 2001; Yue et al., 2006; Hatton, 1997). Changes in protein expression and gene upregulation 
contribute to the functional adaptations of MNCs in response to sustained increases in external 
osmolality (Glasgow et al., 2000; Burbach et al., 2001; Yue et al., 2006). The movement of 
channels and receptors from the cytoplasm to the MNC membrane through translocation is another 
adaptation present in MNCs (Tanaka et al., 1999; Shuster et al., 1999). 
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1.3.2.3 Changes in MNC plasma membrane channel and receptor presence  
 
Mammals that are subjected to dehydration for periods lasting multiple days adjust to the increased 
need for water conservation through multiple mechanisms (Robertson et al., 1976; Hurbin et al., 
2002). MNCs respond by enhancing VP production and release to conserve water at the kidneys 
(for more information on VP, see section 1.2.3; Bourque, 2008). There is an increase in MNC 
plasma membrane vasopressin-1a receptor (VR1a) levels in response to dehydration (Hurbin et al., 
2002). The increase in membrane bound VR1a is due to a process called translocation (Hurbin et 
al., 2002). Translocation is a process by which ion channels and membrane receptors are inserted 
into the plasma membrane (Teruel and Meyer, 2000), and is described in further detail in section 
1.4.3. Stimulating VR1a on MNCs can also lead to an increase in MNC firing and an increase in 
plasma membrane VR1a density via translocation (Hurbin et al., 2002).  
 
Na+ channels translocate to the plasma membrane and increase electrical activity in MNCs in 
response to progressive dehydration (Tanaka et al., 1999). The increase in membrane Na+ channel 
density and open probability decreases the threshold for AP firing and contributes to enhanced 
MNC activity (Tanaka et al., 1999). MNCs therefore possess the adaptive ability to change their 
intrinsic electrical properties in response to hyperosmotic stress (i.e., dehydration; Tanaka et al., 
1999). 
 
High osmolality increases MNC plasma membrane 𝜅-opioid receptor levels (Shuster et al., 1999). 
Intraperitoneal injections of hyperosmotic saline were given to mice, and MNCs were isolated 
from SONs 60 minutes after injection (Shuster et al., 1999). The mice injected with hyperosmotic 
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saline had increased the amount of 𝜅-opioid receptor-1 (𝜅OR1) present on the MNC plasma 
membrane compared to the MNCs of mice that were not injected with hyperosmotic saline 
(Shuster et al., 1999). The amount of plasma membrane 𝜅OR1 in the hyperosmotic-injected mice 
was also higher than the amount of 𝜅OR1 associated with the membranes of intracellular vesicles 
in MNCs, suggesting osmotically induced translocation of 𝜅OR1 to the plasma membrane occurs 
in MNCs in response to exposure to hyperosmotic saline (Shuster et al., 1999). Dynorphin is an 
endogenous opioid peptide that is known to stimulate 𝜅OR1 (Chavkin et al., 1982). In supraoptic 
neurons dynorphin can be packaged in the same vesicles as VP (Whitnall et al., 1983), which can 
be released from the dendrites and axon terminals of MNCs (Pow and Morris, 1989). Dynorphin 
and VP that are released from MNC dendrites decreases Ca2+ influx and neuropeptide release 
(Brown and Bourque, 2004; Brown and Bourque, 2006). The combination of dynorphin release 
and increase in membrane 𝜅OR1 density in MNCs results in autocrine regulation of MNC firing 
to promote phasic firing of MNCs under hyperosmotic stress, which helps control VP and OT 
release (Shuster et al., 1999; Brown and Bourque, 2004; Brown and Bourque, 2006). 
 
1.3.2.4 Changes in protein expression in MNCs 
 
In addition to enhancing VP production, dehydration also increases VR1a mRNA levels and 
synthesis of new VR1a in MNCs (Hurbin et al., 2002). Increasing water load (i.e., lowering body 
osmolality) decreases VP production, VR1a mRNA levels, and VR1a synthesis in MNCs (Hurbin 
et al., 2002). The co-expression of VP and its autoreceptor, VR1a, suggests that the nuclear 
pathways that result in their synchronized regulation are interconnected or similar (Hubrin et al., 
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2002), and that changes in VR1a levels and VP are important in the long-term functional 
adaptations of MNCs. 
 
A slower increase in Na+ channel expression (i.e., the synthesis of new Na+ channels) was also 
shown to occur in MNCs after animals were injected with hyperosmotic saline (Tanaka et al., 
1999). The increase in Na+ channel expression suggests that it is part of a longer-term response of 
MNCs to high osmolality and helps MNCs to then insert new Na+ channels into the membrane 
when needed (Tanaka et al., 1999). 
 
1.4 Exocytosis, endocytosis, and translocation 
 
Exocytosis and endocytosis are two fundamentally important processes in cellular physiology 
(Ceccarelli et al., 1973; Heuser and Reese, 1981). Exocytosis is a process by which cytoplasmic 
vesicles fuse with the plasma membrane (Ceccarelli et al., 1973). A vesicle that will undergo 
exocytosis may contain contents within its membrane to be expelled (e.g., wastes or 
neurotransmitters), or contain channels or receptors incorporated into its membrane to then be 
fused with the plasma membrane (Chen and Scheller, 2001). Empty vesicles also undergo 
exocytosis and fuse with the plasma membrane (Chen and Scheller, 2001). Endocytosis is a 
process that brings molecules or substances (e.g., nutrients, proteins, or foreign pathogens) into 
the cell for further processing or degradation, or returning membrane proteins into vesicles (Pastan 
and Willingham, 1985). Because both processes are essential for cellular survival there are 
multiple mechanisms by which they occur (Miaczynska and Stenmark, 2008; Battey et al., 1999), 
with the most common form of exocytosis being through the soluble N-ethylmaleimide sensitive 
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factor attachment protein receptor (SNARE)-mediated exocytosis (Chen and Scheller, 2001; 
Zorec, 2018), and the most common form of endocytosis being clathrin/dynamin-mediated 
endocytosis (Battey et al., 1999; Raimondi et al., 2011). 
 
1.4.1 SNARE-mediated exocytosis 
 
SNARE-mediated exocytosis of channels contained in intracellular vesicles is an evolutionary 
mechanism in neurons designed to minimize the delay in transmission between pre- and post-
synaptic sites (Sabatini and Regehr, 1999). SNARE is a complex that involves a variety of proteins 
present at or near the intracellular plasma membrane or on the vesicle, including SNAP25, 
synaptobrevin, synaptotagmin, syntaxin, N-methylmaleimide sensitive factor (NSF), 𝛼-SNAP, 
and n-Sec-1 (Zorec, 2018; Montana et al., 2009). Intracellular Ca2+ signals intracellular vesicles 
containing the proteins synaptotagmin and synaptobrevin to travel to the membrane (Zorec, 2018; 
Boron and Boulpaep, 2017). Once at the membrane, n-Sec-1 dissociates from syntaxin and allows 
synaptobrevin to attach and form a complex together with itself and SNAP-25 (Zorec, 2018; Boron 
and Boulpaep, 2017). This complex is known as the SNARE complex. Once the complex is 
formed, 𝛼-SNAP and NSF attach to the complex (Zorec, 2018). Ca2+ influx triggers the vesicle to 
begin to fuse with the membrane by binding to synaptotagmin, but fusion will not occur without 
ATP hydrolysis by the ATPase NSF (Vivona et al., 2013). Once ATP hydrolysis occurs via NSF 
the vesicle fuses with the membrane (Vivona et al., 2013). 
 
Fast synaptic neurotransmission involves the rapid translocation of synaptic vesicles from the axon 
terminal to the membrane, where the vesicles fuse with the membrane and release their contents 
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(e.g., neurotransmitters) onto effector cells like neurons and muscle fibers (Vivona et al., 2013). 
Synaptic neurotransmission requires higher [Ca2+]i in the terminal to initiate translocation and is 
extremely rapid (Boron and Boulpaep, 2017). This fast type of SNARE-mediated exocytosis 
involves synaptotagmin isoforms that are less Ca2+-sensitive to enable more rapid translocation 
and release of neurotransmitter for neuronal communication, as the exocytotic machinery is 
present near the plasma membrane and can detect the rapid influx of Ca2+ coming from nearby L-
type Ca2+ channels (Boron and Boulpaep, 2017). For example, MNCs receive input from 
osmoreceptors in the OVLT and SFO through synaptic neurotransmission and the release of 
neurotransmitters like GLUT to rapidly transmit osmosensory information (Bourque et al., 1994). 
This rapid transmission enables MNCs to then enhance their sensitivity to changes in external 
osmolality and adjust their firing rate and hormone release accordingly (Bourque et al., 1994). 
 
Hormone release is generally a slower process than synaptic transmission (Boron and Boulpaep, 
2017). It requires higher [Ca2+]i than synaptic transmission, but occurs over a longer period of time 
(Zorec, 2018; Boron and Boulpaep, 2017). The slow Ca2+ buildup is sensed by synaptotagmin 
isoforms that are more Ca2+-sensitive and are located further away from the plasma membrane 
(Zorec, 2018; Boron and Boulpaep, 2017). Hormone release is an endocrine response that involves 
release of hormones into the blood to travel to an effector cell or organ and therefore does not 
require the immediate response that synaptic transmission requires (Boron and Boulpaep, 2017). 
For more information on hormone release in MNCs see section 1.2.3. 
 
SNARE-mediated exocytosis can also be modulated by second messenger pathways like the PLC 
pathway (Zorec, 2018; Segovia et al., 2010). This type of SNARE-mediated exocytosis is a slower 
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process than hormonal release and can be used for the translocation and incorporation of channels 
and receptors to the plasma membrane (Zorec, 2018; Boron and Boulpaep, 2017). PKC activation 
by PLC enables PKC to phosphorylate parts of the SNARE complex and promotes translocation 
of vesicles to the plasma membrane as well as fusion of vesicles with the plasma membrane 
(Camprubí-Robles et al., 2009; Montana et al., 2009). In nociceptors, noxious (painful) stimuli 
promote SNARE-mediated insertion of TRPV1 channels in a PKC-dependent manner to the cell 
body membrane in order to enhance depolarization and likelihood of AP firing, thereby enhancing 
nociceptor sensitivity to the noxious stimuli (Camprubí-Robles et al., 2009). PKC activation 
influences the translocation and the exocytosis of certain receptors and channels and is involved 
in the functional adaptations of neurons (Strong et al., 1987; Morgan and Burgoyne, 1992; Newton, 
2001; Morenilla-Palao et al., 2004; Camprubí-Robles et al., 2009; Planells-Cases et al., 2011). 
 
1.4.2 Dynamin-mediated endocytosis 
 
Dynamin is a chief mediator of cellular endocytosis (Shpetner and Vallee, 1989; Koenig and Ikeda, 
1989). It is a GTPase that is involved in modulating the amount of clathrin present on the external 
cell membrane (Damke et al., 1994; Vallis et al., 1999) and is essential for internal membrane 
fission for vesicle and receptor internalization (Henley et al., 1998). Multiple isoforms of dynamin 
exist (Raimondi et al., 2011), with dynamin-1 being expressed in the highest concentration in 
neurons (Nakata et al., 1991; Ferguson et al., 2007). Dynamin senses membrane indentation and 
polymerizes into helices around the newly formed endocytic bud where GTPase activity is 
increased (Ford et al., 2011). It then promotes membrane fission and therefore release of the newly 
formed internalized vesicle into the cell (Liu et al., 2011).  
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1.4.3 Translocation and neuronal modulations 
 
Somatic translocation is a dynamic and reversible process that involves the movement of channels 
and receptors to the plasma membrane from internal stores (Teruel and Meyer, 2000). SNARE-
mediated exocytosis is the primary method of membrane insertion for these translocated channels 
and receptors (Teruel and Meyer, 2000; Zorec, 2018). Some receptors and channels are 
internalized when a stimulus is removed and they are no longer required on the plasma membrane 
(Vieira et al., 1996; Carroll et al., 2001; Henley et al., 1998). This can occur through mechanisms 
like dynamin-mediated endocytosis (Henley et al., 1998; Morenilla-Palao et al., 2004; Camprubí-
Robles et al., 2009). During neurotransmitter release, the depolarization caused by the AP that 
reaches the axon terminal triggers Ca2+ influx through VGCCs and signals synaptic vesicles that 
are docked at the plasma membrane to fuse with the membrane, releasing their contents onto 
effector cells (Hatton, 1990; Armstrong, 1995), usually through SNARE-mediated exocytosis 
(Pryer et al., 1992; Rothman, 1994; Sudhof, 1995). In the cell body a variety of ion channels and 
receptors translocate to the plasma membrane when a stimulus is presented to the neuron (Wan et 
al., 1997; Lan et al., 2001; Jeske et al., 2009; Morenilla-Palao et al., 2004; Planells-Cases et al., 
2011). Exogenous stimulation can stimulate translocation of 𝛾-aminobutyric acid-A receptors 
(GABA-ARs; Wan et al., 1997) and N-methyl-D-aspartate receptors (NMDARs; Lan et al., 2001). 
Stimulation with certain growth factors like nerve growth factor (NGF) can stimulate translocation 
of ion channels like TRPC5 and TRPC3 (Clapham, 2003; Singh et al., 2004) as well as TRPV1 
(Jeske et al., 2009). Neuronal translocation aids functional adaptations of neurons to facilitate 
phenomena like neuronal plasticity, electrical excitability and sensitivity to exogenous stimuli 
(Burgoyne and Morgan, 1993; Cocucci et al., 2006). 
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The ability of certain receptors and ion channels to translocate to the membrane when needed and 
to be internalized when not needed is a functional adaptation of cells like neurons to be able to 
cope with a constantly changing external environment (Carroll et al., 2001; Cocucci et al., 2006; 
Boron and Boulpaep, 2017). TRPV1 translocation specifically is essential in nociceptors and 
sensory neurons to enhance the neuronal sensitivity to noxious and sensory stimuli, respectively 
(Morenilla-Palao et al., 2004; Camprubí-Robles et al., 2009; Planells-Cases et al., 2011; Jeske et 
al., 2009). In response to noxious stimuli TRPV1 will translocate to nociceptor plasma membranes 
to enhance the ability of the nociceptor to fire APs to transmit the information about the noxious 
stimuli in order to enhance a retractive and protective response from the organism (Morenilla-
Palao et al., 2004; Camprubí-Robles et al., 2009). When the noxious stimulus is removed, TRPV1 
will be internalized and the nociceptor will return to its basal firing state (Morenilla-Palao et al., 
2004; Camprubí-Robles et al., 2009). In MNCs, somatic translocation of various ion channels, 
receptors, and neurocrine molecules influence the sensitivity of MNCs to changes in osmolality 
(Shuster et al., 1999; Tanaka et al., 1999; Brown and Bourque, 2004; Bourque, 2008).  
 
1.5 Recent evidence for the role of PLC𝜹1 in MNC osmoregulation 
 
The current focus of our laboratory’s research is on the structural adaptations of MNCs under 
hyperosmotic stress. We use a combination of electrophysiology and biochemical assays like 
immunocytochemistry and immunohistochemistry for in vitro experimentation to understand more 
clearly the underlying mechanisms behind MNC osmoregulation. Our laboratory recently 
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developed a protocol to examine MNC hypertrophy in isolated cells (Shah et al., 2014), as many 
potential aspects of MNC hypertrophy are difficult to study in vivo.  
 
The enhancement of water reabsorption by VP enables animals to endure longer periods without 
water, which enhances survivability in situations where water may not be readily available days 
or weeks (Knepper et al., 2015). The opening of ∆N-TRPV1 channels in MNCs in response to 
sustained increases in osmolality can aid in enhancing AP firing and hormone output, but how or 
whether these currents are integrated with MNC hypertrophy are unknown. It is possible that in 
addition to the increase in ∆N-TRPV1 conductance there is an increase in the number of ∆N-
TRPV1 channel density on the MNC plasma membrane during sustained increases in osmolality 
that were inserted through translocation. The mechanisms that govern short-term osmoregulation 
may also be involved in the long-term responses, but the increase in ion channel density, gene 
expression, and MNC size in response to sustained hyperosmolar exposure suggests that there may 
be additional mechanisms responsible for the long-term adaptations of MNCs to hyperosmolality 
that enable sustained high levels of AP firing and hormone release.   
 
1.5.1 Evidence for the mechanisms of hypertrophy in isolated MNCs 
 
Shah et al., (2014) observed hypertrophy in isolated MNCs. This study involved exposing isolated 
MNCs to hyperosmotic solution for 90 minutes, instead of periods of days of dehydration that 
were used for the in-situ experiments previously described (Modney and Hatton, 1989). It is 
important to note, however, that the increase in cell size observed in vitro was modest (107% 
compared to control; Shah et al., 2014) compared to the hypertrophy observed in situ (170% 
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compared to control; Modney and Hatton, 1989). In addition to observing MNC hypertrophy in 
vitro, they showed that MNC hypertrophy was also dependent on APs, Ca2+ influx through L-type 
Ca2+ channels, increases in [Ca2+]i, TRPV1 currents, PLC, and PKC, as performing the experiment 
in the presence of blockers of these parameters prevented hypertrophy (Shah et al., 2014). They 
also tested whether exocytosis and endocytosis were respectively required for the initiation and 
reversal of hypertrophy by performing the experiment in the presence of an inhibitor of the SNARE 
complex as well as a dynamin inhibitor and found that blocking SNARE-mediated exocytosis 
prevented hypertrophy from occurring, and that blocking dynamin-mediated endocytosis 
prevented the recovery from hypertrophy (Shah et al., 2014). They also examined plasma 
membrane PIP2 concentrations and found that hyperosmotic triggered a decrease in PIP2 
immunofluorescence (Shah et al., 2014). These findings led our laboratory to hypothesize that PLC 
and PKC are both required for MNC hypertrophy, and that hyperosmotic stimulation alone could 
trigger PLC activation. 
  
1.5.2 The role of a Ca2+-dependent PLC isoform in osmotically evoked ∆N-TRPV1 currents 
 
A study by our laboratory in 2017 showed that the osmotically evoked increase in ΔN-TRPV1 
currents in isolated MNCs requires Ca2+. Similar to a previous study by our laboratory (Shah et 
al., 2014), they examined PIP2 immunofluorescence in isolated MNCs under different 
experimental conditions. They found that hyperosmotic stimulation or the addition of the Ca2+ 
ionophore A-23187 to isosmotic solution resulted in a decrease in PIP2 immunofluorescence, while 
inhibiting PLC using U-73122 or removing Ca2+ using BAPTA-AM in hyperosmotic solution 
prevented the decrease in PIP2 immunofluorescence, suggesting that Ca2+ alone could activate PLC 
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(Bansal and Fisher, 2017). Next, they examined the effects of the known PLC activator Ang II on 
PIP2 immunofluorescence and osmotic activation (for more information on Ang II and its 
connection to PLC, see section 1.3.1.2). Isolated MNCs in isosmotic solution were exposed to Ang 
II, which resulted in a decrease in PIP2 immunofluorescence (Bansal and Fisher, 2017). When PLC 
activation by Ang II was combined with hyperosmotic stimuli, there was no additional increase in 
PIP2 immunofluorescence from administering these treatments separately (Bansal and Fisher, 
2017). This observation suggested that osmotic activation of PLC and PLC activation by Ang II 
may depend on the same intracellular pathways (Bansal and Fisher, 2017). Lastly, isolated MNCs 
in isosmotic solution were exposed to the PLC activator m-3M3FBS and a similar decrease in PIP2 
immunofluorescence was observed (Bansal and Fisher, 2017), suggesting that the mechanisms 
underlying osmotic PLC activation are similar to the mechanisms by which Ang II activates PLC 
(Bansal and Fisher, 2017).  To examine the effects of PLC and PKC on baseline and osmotically 
evoked ∆N-TRPV1 currents they first exposed isolated MNCs in isosmotic solution to a PKC 
activator (phorbol 12-myristate 13-acetate) and found that it increased basal ∆N-TRPV1 currents 
as well as osmotically evoked ∆N-TRPV1 currents when a hyperosmotic solution was added 
(Bansal and Fisher, 2017).  Osmotic activation of PLC via a hyperosmotic solution enhanced ΔN-
TRPV1 activity while PLC inhibition by U-73122 reduced osmotically evoked ΔN-TRPV1 
currents in isolated MNCs (Bansal and Fisher, 2017). PKC inhibition by GF-109203 also reduced 
osmotically evoked ΔN-TRPV1 currents in MNCs (Bansal and Fisher, 2017). They suggested that 
because osmotically evoked PLC requires Ca2+, and ΔN-TRPV1 currents are decreased by PLC 
inhibition, MNCs potentially express a Ca2+-dependent PLC pathway that is activated by MNC 
depolarization and Ca2+ influx through L-type Ca2+ channels (Bansal and Fisher, 2017), and that 
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this Ca2+-dependent PLC isoform enhances osmotically evoked ΔN-TRPV1 currents that requires 
PKC activation (Bansal and Fisher, 2017).  
 
1.5.3 Evidence for the role of PLC𝜹1 in modulating osmotically evoked F-actin 
polymerization and ∆N-TRPV1 currents 
 
The findings by Bansal and Fisher in 2017 led our laboratory to hypothesize that the PLC isoform 
responsible could be a member of the PLC𝛿 family (for more information on PLC mechanisms, 
see section 1.3.1.1). We sought to examine the role of the PLC𝛿1 isoform in osmoregulation by 
using transgenic mice that lacked this enzyme (PLC𝛿1 knockout [KO] mice). KO mice are 
genetically modified mice that have had their genomes altered to affect expression of certain 
proteins (Austin et al., 2004). We received PLC𝛿1 KO mice from colleagues in Japan (Yoshikazu 
Nakamura and Kiyoko Fukami). These KO mice lack PLC𝛿1 and do not express it anywhere in 
their bodies (Nakamura et al., 2003). Phenotypically, they do not appear to have an issue with 
drinking water or resting blood osmolality (Nakamura et al., 2003; Park et al., 2021). In our first 
experiment we subjected control (C57BL/6J) mice and PLC𝛿1 KO mice to 24-hour dehydration 
and examined their blood serum osmolality. The PLC𝛿1 KO mice exhibited significantly higher 
serum osmolality than the control mice, suggesting that their systemic osmoregulation is 
dysfunctional (Park et al., 2021). We next examined whether PLC𝛿1 played a role in F-actin 
polymerization. It was previously shown that Ang II-dependent F-actin polymerization in MNCs 
is activated by PLC (Zhang et al., 2007b; Prager-Khoutorsky and Bourque, 2010; Zhang and 
Bourque, 2008). We had also previously shown that osmotic PLC activation likely occurs in a 
manner similar to that of Ang II-mediated PLC activation and that the PLC isoform involved is 
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highly Ca2+-dependent (Bansal and Fisher, 2017). We exposed isolated MNCs from control mice 
to hyperosmotic solution and found that hyperosmotic stimuli cause an increase in subcortical F-
actin polymerization similar to that caused by Ang II (Park et al., 2021). However, when the same 
experiment was repeated in PLC𝛿1 KO mice, no osmotically induced increase in F-actin 
polymerization was observed (Park et al., 2021). Interestingly there was also no increase in F-actin 
in PLC𝛿1 KO mice when exposed to Ang II (Park et al., 2021). It is known that the PLC isoform 
involved in F-actin polymerization is from the PLC𝛽 family (Poitras et al., 1998), but we suggested 
that PLC𝛿1 may be required for the full degree of F-actin polymerization and stimulation of PLC𝛽 
(Park et al., 2021). Next, we aimed to determine whether the MNCs of PLC𝛿1 produced 
osmotically evoked increases in MNC firing or ∆N-TRPV1 currents. We measured both 
parameters in control and PLC𝛿1 KO mice and observed an osmotically evoked increase in both 
AP firing and in ∆N-TRPV1 cation currents in control mice but not in PLC𝛿1 KO mice (Park et 
al., 2021). These findings led us to suggest that PLC𝛿1 plays a critical role in the osmotic activation 
of ∆N-TRPV1 and F-actin polymerization in MNCs (Park et al., 2021). The discovery of the 
potential involvement of PLC𝛿1 in MNC osmoregulation (Park et al., 2021) helps to further 
elucidate the physiological role of PLC𝛿1 in neurons as well as in potential underlying 
mechanisms of MNC osmoregulation. 
 
1.6 Proposed model of osmosensory transduction in MNCs 
 
Increases in external osmolality cause cellular shrinkage due to osmosis (refer to section 1.1 for 
more information on osmosis and cell volume changes). The cell shrinkage causes the 
mechanosensitive ∆N-TRPV1 channels present on the MNC plasma membrane to open (refer to 
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section 1.2.5 for more information on ∆N-TRPV1 channels), which then causes cation influx 
through ∆N-TRPV1 leading to MNC depolarization. This depolarization causes L-type Ca2+ 
channels present on the MNC plasma membrane to open and generate an influx of Ca2+. In addition 
to the depolarization caused by ∆N-TRPV1, osmoreceptors from the OVLT and SFO increase their 
firing in response to the increase external osmolality and release GLUT onto MNCs, which then 
enables more cation influx and depolarization (refer to section 1.2.2 for more information on 
excitatory input from the OVLT and SFO onto MNCs). The high level of depolarization coming 
from ∆N-TRPV1 channels, L-type Ca2+ channels, and cation channels activated by GLUT 
stimulation enables MNCs to reach the depolarization threshold for AP firing and enhances MNC 
AP firing. The AP firing further enhances Ca2+ influx through L-type Ca2+ channels. The increase 
in [Ca2+]i then activates a Ca2+-dependent PLC isoform, which we believe to be PLC𝛿1 (based on 
the evidence presented in section 1.5.2 and section 1.5.3.). PLC𝛿1 then feeds back to ∆N-TRPV1 
channels in a number of ways. PLC𝛿1 activation can enhance cortical F-actin polymerization, 
which enhances ∆N-TRPV1 mechanosensitivity and ability to transduce the hyperosmotically 
evoked decrease in cell volume into depolarizing currents. PLC𝛿1 also cleaves PIP2 into IP3 and 
DAG (refer to section 1.3.1.1 for more information on PLC), and the decrease in PIP2 could 
modulate ∆N-TRPV1 activity (Lukacs et al., 2007). DAG then activates PKC, which can then 
phosphorylate ∆N-TRPV1 and enhance its activity (Bhave et al., 2002; Studer and McNaughton, 
2010). These adaptations are all relatively rapid and can occur within minutes of exposure to 
hyperosmolality, and they could all contribute to the acute osmotic activation of MNCs, but we 




CHAPTER 2: HYPOTHESES AND RESEARCH OBJECTIVES 
 
Previous studies by our laboratory observed MNC hypertrophy in vitro and that it required APs, 
∆N-TRPV1, PLC, PKC, Ca2+, SNARE-mediated exocytosis and Ca2+ influx through L-type Ca2+ 
channels for hypertrophy to occur, and dynamin-mediated endocytosis for the recovery of 
hypertrophy to occur (Shah et al., 2014). We also observed that a Ca2+-dependent isoform of PLC 
mediates osmotically evoked ∆N-TRPV1 currents (Bansal and Fisher, 2017). Our most recent 
study showed that PLC𝛿1 is involved in mediating osmotically evoked ∆N-TRPV1 currents and 
F-actin polymerization, and that mice that lack this enzyme exhibit dysfunctional systemic 
osmoregulation (Park et al., 2021). ∆N-TRPV1 is an important channel in osmoregulation (Zaelzer 
et al., 2015), produces increased currents during hyperosmotic challenge (Oliet and Bourque, 
1993; Sharif-Naeini et al., 2006), and TRPV1 translocation occurs in other neurons and is mediated 
by PLC, PKC, and SNARE-mediated exocytosis (Morenilla-Palao et al., 2004; Planells-Cases et 
al., 2011; Camprubí-Robles et al., 2009). Based on these findings, our goal for this project was to 
determine whether an osmotically induced increase in the density of ∆N-TRPV1 channels on the 
MNC plasma membrane occurred and could contribute to how MNCs are able to sustain high AP 






We designed the following hypotheses and tested them using the in vitro model previously used 
by our laboratory to further study the possibility of osmotically induced ∆N-TRPV1 translocation 
in MNCs: 
 
1. Hyperosmotic stimulation induces a reversible increase in MNC plasma membrane ∆N-
TRPV1 density. 
2. The osmotically induced increase in membrane ∆N-TRPV1 is PLC and PKC dependent. 
3. The osmotically induced increase in membrane ∆N-TRPV1 requires SNARE-mediated 
exocytosis, and the recovery from the increase requires dynamin-mediated endocytosis. 
4. The osmotically induced increase in membrane ∆N-TRPV1 requires translocation of 
vesicles from the Golgi to the plasma membrane. 
5. The isoform of PLC responsible for the osmotic changes in plasma membrane ∆N-TRPV1 
density is PLC𝛿1. 
 
The objectives of this thesis are to elucidate the mechanisms surrounding sustained AP firing and 
hormone release, as well as hypertrophy, of MNCs exposed to high external osmolality. This 
project will aid in the understanding of the physiological relevance and function of osmotically 
evoked MNC hypertrophy, as well as to elucidate a possible mechanism by which MNCs are able 
to sustain a high degree of AP firing and hormone release during sustained exposure to 
hyperosmolality. These goals will enhance our understanding of the mechanisms underlying 
mammalian osmoregulation.   
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CHAPTER 3: MATERIALS AND METHODS 
 
3.1 Ethical Approval 
 
This work was approved by the University of Saskatchewan's Animal Research Ethics Board 
(Fisher: 2001-0066) and adhered to the Canadian Council on Animal Care guidelines for humane 
animal use. 
 
3.2 Animals and Cellular Preparation 
 
Male Long Evans rats aged 8-14 weeks were utilized for all rat experiments. Male C57BL/6J mice 
aged 8-10 weeks were utilized for the control mouse experiments. Both the rats and control mice 
were purchased from Charles River Laboratories (Laval, Quebec, Canada). PLC𝛿1 KO mice were 
originally acquired from Dr. Kiyoko Fukami of the Tokyo University of Pharmacy and Life 
Sciences in Japan, then bred in the University of Saskatchewan’s Laboratory Animal Services Unit 
(LASU), then utilized at 8-10 weeks of age. All animals were anaesthetized using isoflurane and 
sacrificed by decapitation using a guillotine. Brains were promptly removed and tissue blocks 
containing a majority of the two supraoptic nuclei were immediately extracted from the brain and 
placed in an oxygenated (100% O2) isotonic (295 ± 5 mOsm kg⁻¹ for rats, 310 ± 5  mOsm kg-1 
for mice) Pipes solution (pH 7.1) composed of (in mM): NaCl, 110; KCl, 5; MgCl2, 1; CaCl2, 1; 
Pipes, 20; glucose, 25, as well as bovine trypsin (Type XI, 0.6 mg mL-1) in order to loosen the 
extracellular matrix surrounding the MNCs for 90 minutes at 37℃. Then, blocks were moved into 
an oxygenated isotonic PGC solution without trypsin and incubated for 30 minutes at room 
temperature (25℃; RT). Tissue blocks were then triturated using flame-polished pipettes until a 
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cell-suspension containing mostly isolated MNCs was reached (about 500 𝜇L total volume). The 
cell-suspension solution was then plated evenly onto 3 glass-bottomed dishes and allowed to settle 
undisturbed for 20 minutes.  
 
All drugs listed in section 3.3 were prepared in either water or dimethyl sulfoxide (DMSO). DMSO 
concentrations did not exceed 0.1% final volume, which has been proven to be safe for use in 





 A non-selective competitive phospholipase C inhibitor (Smith et al., 1990). It was purchased from 
Enzo Life Sciences (Farmingdale, New York, USA) and applied to cells at a concentration of 1 
𝜇M, which was used previously by our laboratory (Shah et al., 2014). 
 
3.3.2 Bisindolylmaleimide  
A competitive broad-spectrum inhibitor of protein kinase C (Toullec et al., 1991). It was purchased 
from Sigma-Aldrich (St. Louis, Missouri, USA) and applied to cells at a concentration of 1 𝜇M, 
which was used previously by our laboratory (Shah et al., 2014). 
 
 3.3.3 Dynasore  
A competitive inhibitor of dynamin-mediated endocytosis (Macia et al., 2006). It was purchased 
from Sigma-Aldrich and applied to cells at a concentration of 80 𝜇M, which was used previously 
by our laboratory (Shah et al., 2014). 
 
3.3.4 Exo-1  
A competitive inhibitor of exocytosis by inducing the collapse of the Golgi membrane(Feng et al., 
2003). It was purchased from Selleck Chemicals (Houston, Texas, USA) and applied to cells at a 
concentration of 100 𝜇M. 
 
3.3.5 TAT-NSF700 
 A competitive inhibitor of SNARE-mediated exocytosis by blocking the function of N-
ethylmaleimide-sensitive factor (NSF; Calvert et al., 2007). It was purchased from AnaSpec Inc. 
(Fremont, California, USA) and applied to cells at a concentration of 1.2 𝜇M, which was used 
previously by our laboratory (Shah et al., 2014).   
 37 
3.4 Live-cell ∆N-TRPV1 Immunocytochemistry 
 
3.4.1 Isotonic, Hypertonic, Recovery 
 
The 3 dishes were labeled: ISOTONIC (I), HYPERTONIC (H) and RECOVERY (R). Dishes were 
treated with 200 𝜇L of either isotonic (295 ± 5 mOsm kg⁻¹ for rats, 310 ± 5  mOsm kg -1 for mice) 
or hypertonic (325 ± 5 mOsm kg⁻¹ for rats, 340 ± 5 mOsm kg-1 for mice) oxygenated PGC and 
incubated for 15 minutes at RT. 200 𝜇L of each solution was then removed from well and then 
200 𝜇L of either isotonic (I plate) or hypertonic (H and R plates) blocking solution (oxygenated 
Pipes + 5% donkey serum) was added to the corresponding wells and incubated for 45 minutes at 
RT. Next, 200 𝜇L was removed from each well and 200 𝜇L of isotonic (I and R plates) or 
hypertonic (H plate) primary antibody solution (oxygenated Pipes + 5% donkey serum + 3.3 𝜇M 
anti-rat TRPV1 external epitope antibody [from Alomone Laboratories in Jerusalem, Isreal]) was 
added and incubated for 15 minutes at RT. It is important to note that the primary antibody is not 
cell-membrane permeable and would only bind to TRPV1 expressed on the plasma membrane. 
This antibody was affinity-purified by the manufacturer. 200 𝜇L was then carefully removed from 
each well and dishes were then washed 3 times, 200 𝜇L each time with either isotonic (I and R 
plates) or hypertonic (H plate) oxygenated 1x phosphate-buffered solution (PBS) to remove non-
selective antibody binding. The 1x PBS was then removed from the wells and cells were fixated 
for 20 minutes at RT using 200 𝜇L 4% paraformaldehyde (PFA) solution per dish. Once the PFA 
was removed plates were washed 3 times, 200 𝜇L each time with 1x PBS + 0.1% Triton X-100 
(PBST) in order to permeabilize the cells. It should be noted that permeabilization at this step is 
critical to allow the secondary antibody to penetrate the plasma membrane. After the PBST was 
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removed from the wells, 200 𝜇L of secondary antibody solution (PGC + 5% donkey serum + 2 
𝜇M donkey anti-rabbit 488 nm light-sensitive secondary antibody [from Sigma-Aldrich in St. 
Louis, Missouri, USA]) was pipetted into the wells and the dishes were incubated in complete 
darkness for 1 hour at RT. After the secondary antibody solution was removed from each well, 
plates were washed 3 times, 200 𝜇L each time with PBST, then once with 200 𝜇L each 1x PBS in 
order to remove as much non-selective binding or excessive staining as possible. 200 𝜇L of 
solution was removed from each well and Citifluor AF-1 antifade mounting solution (from 
Citifluor in Hatfield, Pennsylvania, USA) was added to each well. The I group was in isotonic 
solution for a total of 90 minutes before fixation. The H group was in hypertonic solution for a 
total of 90 minutes before fixation. The R group was in the hypertonic solution for 60 minutes, and 
the isotonic solution for 30 minutes before fixation. 60 minutes was sufficient time to cause 
significant hypertrophy and 30 minutes was sufficient enough to cause complete recovery. 





3 dishes were labeled: ISOTONIC (I), HYPERTONIC (H), and U-73122 (U). A 100 𝜇M stock 
solution of U-73122 in oxygenated hypertonic Pipes was used for all of the U treatments and 
diluted to 1 𝜇M for each step (i.e., in the initial 15-minute treatment, the 45-minute blocking 
treatment, the 15-minute primary antibody treatment, and the 1x PBS washing) and then diluted 
to 1 𝜇M for each step. The protocol for the I and H treatments identical to the one described in 
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isotonic, hypertonic, recovery. The U-73122 treatment was identical to the H treatment except for 




 3 dishes were labeled: ISOTONIC (I), HYPERTONIC (H), and BISINDOLYLMALEIMIDE (B). 
A 100 𝜇M stock solution of bisindolylmaleimide in oxygenated hypertonic Pipes was used for all 
of the B treatments and diluted to 1 𝜇M for each step (i.e., in the initial 15-minute treatment, the 
45-minute blocking treatment, the 15-minute primary antibody treatment, and the 1x PBS 
washing). The protocol for the I and H treatments was identical to the one described in isotonic, 
hypertonic, recovery. The B treatment was identical to the H treatment except for the presence of 




3 dishes were labeled: ISOTONIC (I), HYPERTONIC (H), and DYNASORE (D). A 1 mM stock 
solution of dynasore in oxygenated hypertonic Pipes was used for the initial 15-minute treatment 
and the 45-minute blocking treatment of the D plate. A 1 mM stock solution of dynasore in 
oxygenated isotonic Pipes was used for the 15-minute primary antibody treatment and the 1x PBS 
washing of the D plate. In each step the stock solution was diluted to 80 𝜇M. The protocol for the 
I and H treatments was identical to the one described in isotonic, hypertonic, recovery. The D 
treatment was identical to the R treatment except for the presence of 80 𝜇M dynasore in all steps 




3 dishes were labeled: ISOTONIC (I), HYPERTONIC (H), and EXO-1 (E). A 1 mM stock solution 
of Exo-1 in oxygenated hypertonic Pipes was used for all of the E treatments and diluted to 100 
𝜇M for each step (i.e., in the initial 15-minute treatment, the 45-minute blocking treatment, the 15-
minute primary antibody treatment, and the 1x PBS washing). The protocol for the I and H 
treatments was identical to the one described in isotonic, hypertonic, recovery. The E treatment 





3 dishes were labeled: ISOTONIC (I), HYPERTONIC (H), and TAT-NSF700 (T). A 100 𝜇M 
stock solution of bisindolylmaleimide in oxygenated hypertonic Pipes was used for all of the T 
treatments and diluted to 1.2 𝜇M for each step (i.e., in the initial 15-minute treatment, the 45-
minute blocking treatment, the 15-minute primary antibody treatment, and the 1x PBS washing). 
The protocol for the I and H treatments was identical to the one described in isotonic, hypertonic, 
recovery. The T treatment was identical to the H treatment except for the presence of 1.2 𝜇M TAT-
NSF700 in all steps prior to fixation. 
  
 41 
CHAPTER 4: DATA COLLECTION AND STATISTICAL ANALYSIS 
 
Images were captured using a Carl Zeiss LSM700 Laser Scanning Microscope (Jena, Germany) 
using a 40x oil-immersion objective. Plates were scanned under the fluorescence of a 470 nm laser 
as this was close to the excitation wavelength of the fluorescent tag AlexaFluor 488 attached to 
the secondary antibody (excitation 𝜆 = 495 nm; emission 𝜆 = 519 nm). The Carl Zeiss Zen Black 
software was used for image capturing on all experiments. Digital gain voltage and laser intensity 
were optimized for the primary experiment to establish a baseline of immunofluorescence that was 
neither over- or under-exposed according to Zen Black, and parameters were thereafter kept 
constant for all experiments to maintain consistency. Any cell that appeared to have a defined 
membrane, an oval-type shape typical of MNCs, and at least one foot process (i.e., somatic 
dendrite) extending from the cell body was deemed healthy and captured for further analysis. Cells 
that appeared lysed, circular, or without a foot process were deemed unhealthy and were not 
captured, as the goal of the experiment was to examine healthy MNCs. The criteria above for 
identifying a healthy MNC was based off of a previous study (Oliet and Bourque, 1992). This 
group also established a criterion for MNC cell size, where 97% of cells with a cross-sectional 
area (CSA) ≥ 200 𝜇m2 were deemed MNCs in rats (Oliet and Bourque, 1992) and in control mice 
(Sharif-Naeini et al., 2008). Z-stack images were captured for all images in order to examine 
captured cells from multiple stage depths. Images were saved periodically as both the original 
Zeiss (.czi) as well as a high-resolution file (.TIFF) compatible with the software utilized for 
analysis. All image analysis was performed using the software ImageJ (from the National Institute 
of Health [NIH] in Bethesda, Maryland, USA). This software had previously been used for MNC 
analysis in our laboratory (Shah et al., 2014; Bansal and Fisher, 2017; Park et al., 2021). A 2 𝜇m2- 
wide pixel brush tool was used to trace the membrane of captured cells. Foot processes were not 
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included in the trace as our focus was plasma membrane  ∆N-TRPV1 density on the cell body. 
Cells chosen to be analyzed were chosen by the definition of the cell membrane and foot process 
(i.e., cell shape and appearance). Microsoft Excel was used to compile the data into charts, and 
GraphPad Prism 7 was used for statistical analysis and graphical production. The cell body 
membrane immunofluorescence and cross-sectional area (CSA) from cells in each treatment group 
were collected in Excel each day analysis was performed. The mean values for each treatment 
group’s immunofluorescence and CSA were then calculated and stored in a master Excel file 
containing the mean values of all treatment groups from each day of experimentation and grouped 
as data sets. All ‘n’ values therefore represent of the number of animals used, not the number of 
cells analyzed. In order for a plate to be considered usable in the data set, at least 8 cells from the 
plate had to be deemed healthy MNCs by the criteria established above. All plates that were imaged 
had between 8-20 usable cells. Every cell that appeared healthy under the microscope was captured 
and analyzed using ImageJ. Since isotonic and hypertonic treatment groups were performed 
alongside each other experimental treatment, the n value of the isotonic and hypertonic groups in 
rats was significantly higher than the other treatments (n= 53 total experiments for isotonic and 
hypertonic treatments compared to n= 8-11 for each other experimental treatment) the data sets 
were split by experiment. For example, the isotonic and hypertonic treatments that were performed 
with the recovery, U-731212, and bisindolylmaleimide experiments were grouped together (as 
seen in Figure 5.2A), and the isotonic and hypertonic treatments that were performed alongside 
the dynasore, Exo-1, and TAT-NSF700 experiments were grouped together (as seen in Figure 
5.2B). All control and PLC𝛿1 KO mouse data sets were grouped as one because fewer total 
experiments were performed (as seen in Figure 5.4 and Figure 5.8, respectively). One-way 
analysis-of-variance (ANOVA) with Bonferroni’s post-hoc test was performed on each data set in 
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order to get a comparison of the means of the data between experimental groups. All data are 
expressed as the mean ± standard deviation (SD). Results were deemed statistically significant if 
P < 0.05 (*), P < 0.01 (**), and P < 0.001 (***). Results for ∆N-TRPV1 immunofluorescence are 
expressed in arbitrary units (a.u.) and results for CSA are expressed in 𝜇m2.  
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CHAPTER 5: RESULTS 
 
5.1 Osmotically induced changes in MNC plasma membrane ∆N-TRPV1 
immunofluorescence under different experimental conditions 
 
The goal of these experiments was to test the hypothesis that hyperosmotic stimulation of isolated 
MNCs triggers ∆N-TRPV1 translocation, and to examine the parameters required for this 
translocation to occur. 
 
5.1.1 Hyperosmotic stimulation induces a reversible increase in plasma membrane ∆N-
TRPV1 levels 
 
MNC plasma membrane ∆N-TRPV1 immunofluorescence was examined in isotonic, hypertonic, 
and recovery treatments (refer to section 3.4.1). MNCs placed in a hypertonic solution displayed 
a significant increase in ∆N-TRPV1 immunofluorescence compared to MNCs in an isotonic 
solution in rats (isotonic: 21.54 ± 2.387, n= 29 to hypertonic: 29.32 ± 2.894, n= 29, P< 0.001) and 
in control mice (isotonic: 22.30 ± 1.146, n= 16 to hypertonic: 30.40 ± 1.797, n= 16, P < 0.001). 
MNCs in the recovery treatment displayed ∆N-TRPV1 immunofluorescence that was significantly 
lower than the hypertonic treatment in rats (hypertonic: 29.32 ± 2.894, n= 29 to recovery: 22.67 
± 2.894, n=11, P < 0.001) and in control mice (hypertonic: 30.40 ± 1.797, n= 16 to recovery: 
23.86 ± 0.939, n= 8, P < 0.001). There was no significant difference between the isotonic and 
recovery groups in rats (isotonic: 21.54 ± 2.387, n= 29 to recovery: 22.67 ± 2.894, n=11, ns) and 
in control mice (isotonic: 22.30 ± 1.146, n= 16 to recovery: 23.86 ± 0.939, n= 8, ns). These data 
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suggest that there is an osmotically induced increase of plasma membrane ∆N-TRPV1 that occurs 
in MNCs and that this process is reversible in both rats and control mice. 
 
5.1.2 Osmotically induced increases in plasma membrane ∆N-TRPV1 are PLC-dependent  
 
MNCs placed in a hypertonic solution containing 1 𝜇M U-73122 (refer to section 3.4.2) exhibited 
significantly lower ∆N-TRPV1 immunofluorescence compared to MNCs placed in a hypertonic 
solution without U-73122 in rats (hypertonic: 29.32 ± 2.894, n= 29 to U-73122: 20.87 ± 1.105, 
n= 10, P < 0.001). There was no significant difference between the isotonic and U-73122 treatment 
groups in rats (isotonic: 21.54 ± 2.387, n= 29 to U-73122: 20.87 ± 1.105, n= 10, ns). These data 
suggest that the inhibition of PLC by U-73122 prevents osmotically induced increases in plasma 
membrane ∆N-TRPV1. 
 
5.1.3 Osmotically induced increases in plasma membrane ∆N-TRPV1 are PKC-dependent  
 
MNCs placed in a hypertonic solution containing 1 𝜇M bisindolylmaleimide (refer to section 
3.4.3) exhibited significantly lower ∆N-TRPV1 immunofluorescence compared to MNCs placed 
in a hypertonic solution without bisindolylmaleimide in rats (hypertonic: 29.32 ± 2.894, n= 29 to 
bisindolylmaleimide: 21.51 ± 1.050, n= 8, P < 0.001). There was no significant difference between 
the isotonic and bisindolylmaleimide treatment groups in rats (isotonic: 21.54 ± 2.387, n= 29 to 
bisindolylmaleimide: 21.51 ± 1.050, n= 8, ns). These data suggest that the inhibition of PKC by 
bisindolylmaleimide prevents osmotically induced increases in plasma membrane ∆N-TRPV1. 
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5.1.4 Endocytosis is required for the reversal of osmotically induced increases in plasma 
membrane ∆N-TRPV1  
 
MNCs placed in a hypertonic solution, then an isotonic solution, both of which containing 80 𝜇M 
dynasore (refer to section 3.4.4) exhibited a significantly higher plasma membrane ∆N-TRPV1 
immunofluorescence compared to the isotonic treatment in rats (isotonic: 22.65 ± 1.099, n= 24 to 
dynasore: 31.56 ± 1.652, n= 8, P < 0.001). There was also a significant difference between the 
recovery and dynasore treatments in rats (recovery: 22.67 ± 2.894, n=11 to dynasore: 31.56 ± 
1.652, n= 8, P < 0.001). There was no significant difference between the hypertonic and dynasore 
treatments in rats (hypertonic: 30.45 ± 1.274, n= 24 to dynasore: 31.56 ± 1.652, n= 8, ns). Because 
there was a significant difference between the recovery and dynasore treatments and the protocols 
were identical except for the presence of 80 𝜇M dynasore, the data suggests that endocytosis is 
required for the reversal of the osmotically induced increase in plasma membrane ∆N-TRPV1. 
 
5.1.5 Osmotically induced increases in plasma membrane ∆N-TRPV1 require Golgi-derived 
vesicles 
 
MNCs placed in a hypertonic solution containing 100 𝜇M Exo-1 (refer to section 3.4.5) exhibited 
significantly lower ∆N-TRPV1 immunofluorescence compared to MNCs placed in a hypertonic 
solution without Exo-1 in rats (hypertonic: 30.45 ± 1.274, n= 24 to Exo-1: 21.49 ± 0.8827, n= 8, 
P < 0.001) and in control mice (hypertonic: 30.40 ± 1.797, n= 16 to Exo-1: 22.41 ± 0.9389, n= 8, 
P < 0.001). There was no significant difference between the isotonic and Exo-1 treatment groups 
in rats (isotonic: 22.65 ± 1.099, n= 24 to Exo-1: 21.49 ± 0.8827, n= 8, ns) and in control mice 
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(isotonic: 22.30 ± 1.146, n= 16 to Exo-1: 22.41 ± 0.5891, n= 8, ns). These data suggest that the 
inhibition of exocytosis by Exo-1 prevents osmotically induced increases in plasma membrane 
∆N-TRPV1. 
 
5.1.6 Osmotically induced increases in plasma membrane ∆N-TRPV1 require SNARE-
mediated exocytosis 
 
MNCs placed in a hypertonic solution containing 1.2 𝜇M TAT-NSF700 (refer to section 3.4.6) 
exhibited significantly lower ∆N-TRPV1 immunofluorescence compared to MNCs placed in a 
hypertonic solution without TAT-NSF700 in rats (hypertonic: 30.45 ± 1.274, n= 24 to TAT-
NSF700: 21.86 ± 1.019, n= 8, P < 0.001). There was no significant difference between the isotonic 
and TAT-NSF700 treatment groups in rats (isotonic: 22.65 ± 1.099, n= 24 to TAT-NSF700: 21.86 
± 1.019, n= 8, ns). These data suggest that the inhibition of SNARE-mediated exocytotic 
membrane fusion by TAT-NSF700 prevents osmotically induced increases in plasma membrane 
∆N-TRPV1. 
 
The results from the experiments conducted in this section suggest that reversible osmotically 
induced ∆N-TRPV1 translocation occurs in MNCs, and that PLC, PKC, Golgi-derived vesicles, 
and SNARE-mediated exocytosis are required for the translocation, and that dynamin-mediated 






Figure 5.1: Immunocytochemistry images depicting osmotically induced changes in rat MNC 
plasma membrane ∆N-TRPV1 immunofluorescence under different experimental 
conditions. Representative immunocytochemistry images of the graphs presented in Figure 5.2 
and Figure 5.5. (A) Isotonic treatment (295 ± 5 mosmol kg-1). (B) Hypertonic treatment (325 ± 5 
mosmol kg -1). (C) Recovery treatment (hypertonic, then isotonic). (D) Recovery treatment + 80 
𝝁M dynasore. (E) Hypertonic treatment + 1 𝝁M U-73122. (F) Hypertonic treatment + 1 𝝁M 
bisindolylmaleimide. (G) Hypertonic treatment + 100 𝝁M Exo-1. (H) Hypertonic treatment + 1.2 
𝝁M TAT-NSF700.   
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Figure 5.2: Osmotically induced changes in rat MNC plasma membrane ∆N-TRPV1 
immunofluorescence under different experimental conditions. (A) Bar-scatter plot showing 
that osmotically induced increases in plasma membrane TRPV1 immunofluorescence occur, are 
reversible, and require activation of PLC and PKC. TRPV1 labeling of isolated MNCs in 
hypertonic solution was significantly higher than in isotonic solution (isotonic: 21.54 ± 2.387, n= 
29 to hypertonic: 29.32 ± 2.894, n= 29, P< 0.001). TRPV1 labeling was significantly reduced with 
a washout of hypertonic solution with isotonic solution in the recovery treatment (hypertonic: 
29.32 ± 2.894, n= 29 to recovery: 22.67 ± 2.894, n=11, P < 0.001), as well as by the presence of 
the PLC inhibitor U-73122 (hypertonic: 29.32 ± 2.894, n= 29 to U-73122: 20.87 ± 1.105, n= 10, 
P < 0.001) and by the PKC inhibitor bisindolylmaleimide (hypertonic: 29.32 ± 2.894, n= 29 to 
bisindolylmaleimide: 21.51 ± 1.050, n= 8, P < 0.001).  (B) Bar-scatter plot showing that the 



















































































































































































































































































osmotically induced increases in plasma membrane TRPV1 immunofluorescence require vesicles 
from the Golgi and SNARE-mediated exocytosis. TRPV1 labeling of isolated MNCs in recovery 
solution (hypertonic with isotonic washout) containing the dynamin inhibitor dynasore was 
significantly higher than the isotonic treatment (isotonic: 22.65 ± 1.099, n= 24 to dynasore: 31.56 
± 1.652, n= 8, P < 0.001). TRPV1 labeling was significantly diminished in isolated MNCs in 
hypertonic solution containing the Golgi inhibitor Exo-1 (hypertonic: 30.45 ± 1.274, n= 24 to 
Exo-1: 21.49 ± 0.8827, n= 8, P < 0.001) or an inhibitor of SNARE-mediated exocytosis, TAT-
NSF700 (hypertonic: 30.45 ± 1.274, n= 24 to TAT-NSF700: 21.86 ± 1.019, n= 8, P < 0.001). For 
(A), F (4, 87) = 37.52. For (B), F (4, 67) = 223.3.
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Figure 5.3: Immunocytochemistry images depicting osmotically induced changes in 
C57BL/6J (control) mouse MNC plasma membrane ∆N-TRPV1 immunofluorescence under 
different experimental conditions. Representative immunocytochemistry images of the graphs 
presented in Figure 5.4 and Figure 5.6. (A) Isotonic treatment (310 ± 5 mosmol kg-1). (B) 
Hypertonic treatment (340 ± 5 mosmol kg -1). (C) Recovery treatment (hypertonic, then isotonic). 
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Figure 5.4: Osmotically induced changes in C57BL/6J (control) mouse MNC plasma 
membrane ∆N-TRPV1 immunofluorescence under different experimental conditions. Bar-
scatter plot showing that osmotically induced increases in plasma membrane TRPV1 
immunofluorescence occur, are reversible, and require vesicles from the Golgi. TRPV1 labeling 
of isolated MNCs in hypertonic solution was significantly higher than in isotonic solution 
(isotonic: 22.30 ± 1.146, n= 16 to hypertonic: 30.40 ± 1.797, n= 16, P < 0.001). TRPV1 labeling 
was significantly reduced with a washout of hypertonic solution with isotonic solution in the 
recovery treatment (hypertonic: 30.40 ± 1.797, n= 16 to recovery: 23.86 ± 0.939, n= 8, P < 0.001), 
or by the presence of the Golgi inhibitor Exo-1 (hypertonic: 30.40 ± 1.797, n= 16 to Exo-1: 22.41 






































































































5.2 Osmotically induced changes in MNC cross-sectional area under different experimental 
conditions 
 
The experiments conducted previously by our laboratory (Shah et al., 2014) showed that MNC 
hypertrophy requires PLC, PKC, and SNARE-mediated exocytosis, and that the recovery from 
hypertrophy requires dynamin-mediated endocytosis. These experiments were repeated to 
examine whether there are commonalities in the mechanisms governing osmotically evoked MNC 
hypertrophy and osmotically induced ∆N-TRPV1 translocation. They were then conducted in 
control mice to observe whether the model was valid in mice. 
 
5.2.1 Reversible osmotically induced increases in MNC cross-sectional area (CSA) 
 
MNC CSA was examined in isotonic, hypertonic, and recovery treatments (refer to section 3.4.1). 
MNCs placed in a hypertonic solution displayed a significant increase CSA compared to MNCs 
in an isotonic solution in rats (isotonic: 319.97 ± 9.1740 𝜇m2, n= 29 to hypertonic: 347.05 ± 
15.325 𝜇m2, n= 29, P< 0.001) and in control mice (isotonic: 237.71 ± 3.3900 𝜇m2, n= 16 to 
hypertonic: 266.91 ± 7.8319 𝜇m2, n= 16, P < 0.001). MNCs in the recovery treatment exhibited 
significantly lower CSA than the hypertonic treatment in rats (hypertonic: 347.05 ± 15.325 𝜇m2, 
n= 29 to recovery: 336.92 ± 12.730 𝜇m2, n=11, P < 0.001) and in control mice (hypertonic: 266.91 
± 7.8319 𝜇m2, n= 16 to recovery: 246.46 ± 2.8070 𝜇m2, n= 8, P < 0.001). There was no significant 
difference between the isotonic and recovery groups in rats (isotonic: 319.97 ± 9.1740 𝜇m2, n= 29 
to recovery: 336.92 ± 12.730 𝜇m2, n=11, ns) and in control mice (isotonic: 237.71 ± 3.3900 𝜇m2, 
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n= 16 to recovery: 246.46 ± 2.8070 𝜇m2, n= 8, ns). These data suggest that there is an osmotically 
induced increase of MNC CSA that occurs and is reversible in both rats and control mice. 
 
5.2.2 Osmotically induced increases in MNC CSA are PLC-dependent  
 
MNCs placed in a hypertonic solution containing 1 𝜇M U-73122 (refer to section 3.4.2) exhibited 
significantly lower CSA compared to MNCs placed in a hypertonic solution without U-73122 in 
rats (hypertonic: 347.05 ± 15.325 𝜇m2, n= 29 to U-73122: 314.93 ± 9.1992 𝜇m2, n= 10, P < 
0.001). There was no significant difference between the isotonic and U-73122 treatment groups in 
rats (isotonic: 319.97 ± 9.1740 𝜇m2, n= 29 to U-73122: 314.93 ± 9.1992 𝜇m2, n= 10, ns). These 
data suggest that the inhibition of PLC by U-73122 prevents osmotically induced increases in 
MNC CSA from occurring. 
 
5.2.3 Osmotically induced increases in MNC CSA are PKC-dependent  
 
MNCs placed in a hypertonic solution containing 1 𝜇M bisindolylmaleimide (refer to section 
3.4.3) exhibited significantly lower CSA compared to MNCs placed in a hypertonic solution 
without bisindolylmaleimide in rats (hypertonic: 347.05 ± 15.325 𝜇m2, n= 29 to 
bisindolylmaleimide: 320.28 ± 3.2160 𝜇m2, n= 8, P < 0.001). There was no significant difference 
between the isotonic and bisindolylmaleimide treatment groups in rats (isotonic: 319.97 ± 9.1740 
𝜇m2, n= 29 to bisindolylmaleimide: 320.28 ± 3.2160 𝜇m2, n= 8, ns). These data suggest that the 
inhibition of PKC by bisindolylmaleimide prevents osmotically induced increases in MNC CSA 
from occurring. 
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5.2.4 Endocytosis is required for the reversal of osmotically induced increases in MNC CSA 
 
MNCs placed in a hypertonic solution, then an isotonic solution, both of which containing 80 𝜇M 
dynasore (refer to section 3.4.4) exhibited a significant increase in CSA compared to the isotonic 
treatment in rats (isotonic: 322.396 ± 4.413 𝜇m2, n= 24 to dynasore: 352.51 ± 5.8086 𝜇m2, n= 8, 
P < 0.001). There was also a significant difference between the recovery and dynasore treatments 
in rats (recovery: 336.92 ± 12.730 𝜇m2, n=11 to dynasore: 352.51 ± 5.8086 𝜇m2, n= 8, P < 0.001). 
There was no significant difference between the hypertonic and dynasore treatments in rats 
(hypertonic: 339.31 ± 7.9328 𝜇m2, n= 24 to dynasore: 352.51 ± 5.8086 𝜇m2, n= 8, ns). Because 
there was a significant difference between the recovery and dynasore treatments and the protocols 
were identical except for the presence of 80 𝜇M dynasore in the dynasore treatment, the data 
suggests that endocytosis is required for the reversal of the osmotically induced increase in MNC 
CSA. 
 
5.2.5 Osmotically induced increases in MNC CSA require Golgi-derived vesicles 
 
MNCs placed in a hypertonic solution containing 100 𝜇M Exo-1 (refer to section 3.4.5) exhibited 
significantly lower CSA compared to MNCs placed in a hypertonic solution without Exo-1 in rats 
(hypertonic: 339.31 ± 7.9328 𝜇m2, n= 24 to Exo-1: 315.80 ± 2.2635 𝜇m2, n= 8, P < 0.001) and in 
control mice (hypertonic: 266.91 ± 7.8320 𝜇m2, n= 16 to Exo-1: 235.25 ± 3.9890 𝜇m2, n= 8, P < 
0.001). There was no significant difference between the isotonic and Exo-1 treatment groups in 
rats (isotonic: 322.396 ± 4.413 𝜇m2, n= 24 to Exo-1: 315.80 ± 2.2635 𝜇m2, n= 8, ns) and in control 
mice (isotonic: 237.71 ± 3.3900 𝜇m2, n= 16 to Exo-1: 315.80 ± 2.2635 𝜇m2, n= 8, ns). These data 
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suggest that the inhibition of exocytosis by Exo-1 prevents osmotically induced increases in MNC 
CSA from occurring. 
 
5.2.6 Osmotically induced increases in MNC CSA require SNARE-mediated exocytosis 
 
MNCs placed in a hypertonic solution containing 1.2 𝜇M TAT-NSF700 (refer to section 3.4.6) 
exhibited significantly lower CSA compared to MNCs placed in a hypertonic solution without 
TAT-NSF700 in rats (hypertonic: 339.31 ± 7.9328 𝜇m2, n= 24 to TAT-NSF700: 317.224 ± 
3.0330 𝜇m2, n= 8, P < 0.001). There was no significant difference between the isotonic and TAT-
NSF700 treatment groups in rats (isotonic: 322.396 ± 4.413 𝜇m2, n= 24 to TAT-NSF700: 317.224 
± 3.0330 𝜇m2, n= 8, ns). These data suggest that the inhibition of SNARE-mediated exocytotic 
membrane fusion by TAT-NSF700 prevents osmotically induced increases in MNC CSA from 
occurring. 
 
These data confirm that osmotically evoked MNC hypertrophy occurs in control mice, and that 
there are commonalities in the mechanisms governing osmotically induced ∆N-TRPV1 
translocation and hypertrophy.  
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Figure 5.5: Osmotically induced changes in rat MNC cross-sectional area (CSA) under 
different experimental conditions. (A) Bar-scatter plot showing that osmotically induced 
increases in MNC CSA occur, are reversible, and require activation of PLC and PKC. CSA of 
isolated MNCs in hypertonic solution was significantly higher than in isotonic solution (isotonic: 
319.97 ± 9.1740 𝝁m2, n= 29 to hypertonic: 347.05 ± 15.325 𝝁m2, n= 29, P< 0.001). CSA was 
significantly reduced with a washout of hypertonic solution with isotonic solution in the recovery 
treatment (hypertonic: 347.05 ± 15.325 𝝁m2, n= 29 to recovery: 336.92 ± 12.730 𝝁m2, n=11, P < 
0.001), as well as by the presence of the PLC inhibitor U-73122 (hypertonic: 347.05 ± 15.325 
𝝁m2, n= 29 to U-73122: 314.93 ± 9.1992 𝝁m2, n= 10, P < 0.001) and by the PKC inhibitor 
bisindolylmaleimide (hypertonic: 347.05 ± 15.325 𝝁m2, n= 29 to bisindolylmaleimide: 320.28 ± 
3.2160 𝝁m2, n= 8, P < 0.001).  (B) Bar-scatter plot showing that dynamin-mediated endocytosis is 
required for the recovery from hypertrophy, and that osmotically induced increases in MNC CSA 

























































































































































































































































































































































































































MNCs in recovery solution (hypertonic with isotonic washout) containing the dynamin inhibitor 
dynasore was significantly higher than the isotonic treatment (isotonic: 322.396 ± 4.413 𝝁m2, n= 
24 to dynasore: 352.51 ± 5.8086 𝝁m2, n= 8, P < 0.001). TRPV1 labeling was significantly 
diminished in isolated MNCs in hypertonic solution containing the Golgi inhibitor Exo-1 
(hypertonic: 339.31 ± 7.9328 𝝁m2, n= 24 to Exo-1: 315.80 ± 2.2635 𝝁m2, n= 8, P < 0.001) or an 
inhibitor of SNARE-mediated exocytosis, TAT-NSF700 (hypertonic: 339.31 ± 7.9328 𝝁m2, n= 
24 to TAT-NSF700: 317.224 ± 3.0330 𝝁m2, n= 8, P < 0.001). For (A), F (5, 87) = 23.62. For (B), 




Figure 5.6: Osmotically induced changes in C57BL/6J (control) mouse MNC cross-sectional 
area (CSA) under different experimental conditions. Bar-scatter plot showing that osmotically 
induced increases in MNC CSA occur, are reversible, and require vesicles from the Golgi. CSA 
of isolated MNCs in hypertonic solution was significantly higher than in isotonic solution 
(isotonic: 237.71 ± 3.3900 𝝁m2, n= 16 to hypertonic: 266.91 ± 7.8319 𝝁m2, n= 16, P < 0.001). 
CSA was significantly reduced with a washout of hypertonic solution with isotonic solution in the 
recovery treatment (hypertonic: 266.91 ± 7.8319 𝝁m2, n= 16 to recovery: 246.46 ± 2.8070 𝝁m2, 
n= 8, P < 0.001), or by the presence of the Golgi inhibitor Exo-1 (hypertonic: 266.91 ± 7.8320 







































































































5.3 PLC𝜹1 KO mouse MNCs display impaired responses to hyperosmolality 
 
After confirming that osmotically induced ∆N-TRPV1 translocation and osmotically evoked MNC 
hypertrophy occur in both rats and mice, and that both require PLC, our next test was to repeat the 
experiments in PLC𝛿1 KO mice to determine whether PLC𝛿1 is required for ∆N-TRPV1 
translocation and hypertrophy. 
 
5.3.1 Osmotically induced increases in plasma membrane ∆N-TRPV1 require PLC𝜹1 
 
The experiment described in section 3.4.1 was repeated in PLC𝛿1 KO mice. MNCs placed in a 
hypertonic solution did not display a difference in ∆N-TRPV1 immunofluorescence compared to 
MNCs in an isotonic solution (isotonic: 21.37 ± 0.5200, n= 8 to hypertonic: 21.31 ± 0.4385, n= 
8, ns). MNCs in the recovery treatment also did not display any difference in ∆N-TRPV1 
immunofluorescence compared to either the isotonic treatment (isotonic: 21.37 ± 0.5200, n= 8 to 
recovery: 21.15 ± 0.3823, n= 8, ns) or the hypertonic treatment (hypertonic: 21.31 ± 0.4385, n= 
8 to recovery: 21.15 ± 0.3823, n= 8, ns). These data suggest that PLC𝛿1 is required for the 
osmotically induced increase in ∆N-TRPV1 immunofluorescence, as the increase observed in both 
rats and in control mice is not observed in PLC𝛿1 KO mice. 
 
5.3.2 Osmotically induced increases in MNC CSA require PLC𝜹1 
 
The experiment described section 3.4.1 was repeated in PLC𝛿1 KO mice. MNCs placed in a 
hypertonic solution did not display a difference in CSA compared to MNCs in an isotonic solution 
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(isotonic: 233.10 ± 2.1726 𝜇m2, n= 8 to hypertonic: 233.11 ± 1.7395 𝜇m2, n= 8, ns). MNCs in the 
recovery treatment also did not display any difference in ∆N-TRPV1 immunofluorescence 
compared to either the isotonic treatment (isotonic: 233.10 ± 2.1726 𝜇m2, n= 8 to recovery: 232.50 
± 1.6393 𝜇m2, n= 8, ns) or the hypertonic treatment (hypertonic: 233.11 ± 1.7395 𝜇m2, n= 8 to 
recovery: 232.50 ± 1.6393 𝜇m2, n= 8, ns). These data suggest that PLC𝛿1 is also required for the 
osmotically induced increase in MNC CSA, as the increase observed in both rats and in control 
mice is not observed in PLC𝛿1 KO mice. 
 
These data suggest that MNCs isolated from PLC𝛿1 KO mice are unable to undergo osmotically 
evoked hypertrophy or osmotically induced ∆N-TRPV1 translocation. These data may provide an 
explanation for the dysfunctional systemic osmoregulation observed in PLC𝛿1 KO mice, which 
will be discussed in further detail in Chapter 6.  
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Figure 5.7: PLC𝜹1 KO mice do not display hypertrophy or ∆N-TRPV1 translocation in 
response increases in external osmolality. Representative immunocytochemistry images of the 
graphs presented in Figure 5.8 and Figure 5.9. (A) Isotonic treatment (310 ± 5 mosmol kg-1). (B) 








Figure 5.8: PLC𝜹1 KO mice are unable to respond to sustained increases in external 
osmolality through osmotically induced ∆N-TRPV1 translocation. Bar-scatter plot showing 
that PLC𝜹1 KO mice do not have the ability to increase the amount of TRPV1 present on the 
membrane in response to hypertonic solution, as there was no increase in TRPV1 
immunofluorescence between isolated MNCs treated with isotonic or hypertonic solution 
(isotonic: 21.37 ± 0.5200, n= 8 to hypertonic: 21.31 ± 0.4385, n= 8, ns). There was also no change 
in TRPV1 labeling after washout of hypertonic solution with isotonic solution (hypertonic: 21.31 














































































Figure 5.9: PLC𝜹1 KO mice do not display osmotically evoked increases in cross-sectional 
area (CSA). Bar-scatter plot showing that PLC𝜹1 KO mice do not have the ability to undergo 
hypertrophy in response to hypertonic solution, as there was no increase in MNC CSA between 
isolated MNCs treated with isotonic or hypertonic solution ((isotonic: 233.10 ± 2.1726 𝝁m2, n= 8 
to hypertonic: 233.11 ± 1.7395 𝝁m2, n= 8, ns). There was also no change in CSA after washout 
of hypertonic solution with isotonic solution (hypertonic: 233.11 ± 1.7395 𝝁m2, n= 8 to recovery: 













































































CHAPTER 6: DISCUSSION 
 
The structural and functional adaptations of MNCs to sustained high osmolality include changes 
in plasma membrane protein levels and gene expression (Shuster et al., 1999; Tanaka et al., 1999; 
Ghorbel et al., 2003), as well as somatic hypertrophy (Modney and Hatton, 1989; Shah et al., 
2014). Mammals are able to sustain high levels of VP release during periods of dehydration lasting 
days (Wakerly et al., 1978; Modney and Hatton, 1989). The mechanisms by which mammals are 
able to continually fire APs and release VP during periods of dehydration are poorly understood. 
Processes such as Na+ channel translocation, increases in gene expression, and MNC hypertrophy 
are known to occur in response to sustained increases in external osmolality (Tanaka et al., 1999; 
Ghorbel et al., 2003; Miyata and Hatton, 2002; Shah et al., 2014), but it is not yet known why 
these processes exist. Because they do exist, they are likely to be physiologically relevant, and 
because they are different than the processes that regulate short-term osmoregulation, it is likely 
that different mechanisms regulate long-term osmoregulation in MNCs. We demonstrated that an 
osmotically induced translocation of ∆N-TRPV1 channels from internal stores to the MNC plasma 
membrane occurs, and that it operates through the same mechanisms as MNC hypertrophy in vitro, 
which will be discussed in further detail below. This finding suggests that ∆N-TRPV1 
translocation may be a part of the structural and functional adaptations of MNCs to sustained 
increases in external osmolality, which may enable MNCs to sustain a high degree of AP firing 
and hormone release during periods of dehydration. It was also observed that both osmotically 
induced ∆N-TRPV1 translocation and osmotically evoked MNC hypertrophy require PLC𝛿1. This 
chapter will elaborate on the evidence presented in Chapter 5, and will discuss the possible 
physiological implications of osmotically induced ∆N-TRPV1 translocation in MNCs. 
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6.1 Osmotically induced increases in MNC plasma membrane ∆N-TRPV1 occur and are 
reversible 
 
We show here that reversible osmotically induced increases in MNC plasma membrane ∆N-
TRPV1 occur in parallel with osmotically evoked hypertrophy. Stimulating MNCs with 
hyperosmotic solution for a similar time course as previously described (Shah et al., 2014), we 
performed immunocytochemistry experiments to examine the effects of sustained increases in 
external osmolality on MNC plasma membrane ∆N-TRPV1 immunofluorescence in rats and mice. 
We report that there is a significant increase in membrane ∆N-TRPV1 immunofluorescence during 
sustained increases in osmolality (i.e., 1 hour). MNC hypertrophy also occurred during this time. 
Because MNC hypertrophy is a reversible process (Shah et al., 2014), we aimed to also examine 
whether the increase in plasma membrane ∆N-TRPV1 density was reversible. We also report that 
the osmotically induced increase in membrane ∆N-TRPV1 is reversible, as cells in the recovery 
treatment (see section 3.4.1) exhibited a return to isotonic levels of both ∆N-TRPV1 
immunofluorescence and membrane area in rats (see Figure 5.1, Figure 5.2, and Figure 5.5) and 
in control mice (see Figure 5.3, Figure 5.4, and Figure 5.6). This may contribute to the ability of 
MNCs to sustain depolarizing currents over long periods of time, as an increased number of ∆N-






6.2 PLC and PKC are required for the osmotically induced increase in plasma membrane 
∆N-TRPV1 
 
Because previous research suggested that PLC is involved in MNC hypertrophy (Shah et al., 2014) 
as well as TRPV1 translocation in other neurons (Jeske et al., 2009; Zhang et al., 2005), we next 
aimed to determine whether PLC is involved in the osmotically induced increase in ∆N-TRPV1. 
We examined the effects of hypertonic stimuli in the presence of the PLC inhibitor U-73122 (see 
section 3.4.2). We observed that despite being in a hypertonic solution the presence of the PLC 
inhibitor prevented the expected increase in both ∆N-TRPV1 immunofluorescence and membrane 
area (see Figure 5.1, Figure 5.2, and Figure 5.5), which suggests that PLC is required for the 
osmotically induced increase in both ∆N-TRPV1 immunofluorescence and membrane area. 
 
Since PKC is activated downstream of PLC by DAG (Rhee, 2001), is required for MNC 
hypertrophy (Shah et al., 2014), and promotes increases in membrane TRPV1 expression and 
translocation in other neurons (Zhang et al., 2005; Malek et al., 2015), we sought next to determine 
whether PKC activation was required for the osmotically induced increase in membrane ∆N-
TRPV1. Applying the PKC inhibitor bisindolylmaleimide in the presence of a hypertonic solution 
(see section 3.4.3) prevented an increase in both ∆N-TRPV1 immunofluorescence and membrane 
area (see Figure 5.1, Figure 5.2, and Figure 5.5), suggesting that PKC is necessary for the 





6.3 Dynamin-mediated endocytosis is required for retrieval of ∆N-TRPV1 from the plasma 
membrane 
 
Recovery from translocation has been shown to be dependent on dynamin-mediated endocytosis 
(Chen et al., 1991). The recovery from MNC hypertrophy is also dependent on dynamin-mediated 
endocytosis (Shah et al., 2014). Therefore, the next step in determining the mechanisms of the 
reversible osmotically induced increase in plasma membrane ∆N-TRPV1 was to determine 
whether the reversal of the increase we observed was due to dynamin-mediated endocytosis. By 
adding the dynamin inhibitor dynasore to the recovery treatment (see section 3.4.4) we observed 
that the recovery from hypertrophy was blocked. We also observed that dynasore prevented the 
decrease in plasma membrane ∆N-TRPV1 immunofluorescence that was observed in the recovery 
treatment without dynasore (see Figure 5.1, Figure 5.2, and Figure 5.5). This finding suggests that 
dynamin-mediated endocytosis is required for the reversal of the osmotically induced increase in 
membrane ∆N-TRPV1 immunofluorescence. 
 
6.4 Vesicles from the Golgi are required for the osmotically induced increase in plasma 
membrane ∆N-TRPV1 
 
Since movement of channel-containing vesicles derived from the Golgi to the plasma membrane 
are associated with translocation (Alberts et al., 2002), we aimed to determine the effect of 
inhibiting channel movement from the Golgi on osmotically induced plasma membrane ∆N-
TRPV1 levels using the inhibitor peptide Exo-1 (Morgan and Burgoyne, 1992). Isolated MNCs 
exposed to a hypertonic solution containing Exo-1 (see section 3.4.5) showed no increase in either 
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∆N-TRPV1 immunofluorescence or membrane area in rats (see Figure 5.1, Figure 5.2, and Figure 
5.5) or in control mice (see Figure 5.3, Figure 5.4, and Figure 5.6), suggesting that movement of 
∆N-TRPV1 from internally stored vesicles produced by the Golgi are required for the osmotically 
induced increase. 
 
6.5 SNARE-mediated exocytosis is required for the osmotically induced increase in plasma 
membrane ∆N-TRPV1 
 
Because SNARE-mediated exocytosis is required for MNC hypertrophy (Shah et al., 2014) and 
TRPV1 translocation (Planells-Cases et al., 2011; Camprubí-Robles et al., 2009), we next sought 
to determine whether SNARE-mediated exocytotic membrane fusion is required for the increase 
in plasma membrane ∆N-TRPV1. We treated MNCs exposed to hypertonic solution with the 
SNARE complex inhibitor TAT-NSF700 (see section 3.4.6), which inhibits NSF-mediated ATP 
hydrolysis and therefore vesicular membrane fusion, and observed that there was no increase in 
∆N-TRPV1 immunofluorescence or membrane area (see Figure 5.1, Figure 5.2, and Figure 5.5; 
the membrane area experiment was previously conducted by Shah et al., 2014), suggesting that 







6.6 PLC𝜹1 is required for MNC hypertrophy as well as for the osmotically induced increase 
in plasma membrane ∆N-TRPV1 
 
Previous data from our laboratory suggested that a Ca2+-dependent isoform of PLC was required 
for osmotically evoked increases in ∆N-TRPV1 currents (Bansal and Fisher, 2017). We then 
determined that the PLC𝛿1 isoform modulates the increase in ∆N-TRPV1 currents (Park et al., 
2021), and that mice void of this isoform exhibited dysfunctional systemic osmoregulation (Park 
et al., 2021). We therefore sought to determine whether PLC𝛿1 is the isoform responsible for the 
observed osmotically induced increase in ∆N-TRPV1 immunofluorescence. We repeated the 
initial experiments (see section 3.4.1) in PLC𝛿1 KO mice to observe whether an osmotically 
induced increase in ∆N-TRPV1 or membrane area occurred. We report that there is no osmotically 
induced increase in either ∆N-TRPV1 immunofluorescence or membrane area in PLC𝛿1 KO mice 
(see Figure 5.7, Figure 5.8, and Figure 5.9), suggesting that PLC𝛿1 is the isoform of PLC involved 
in mediating both increases in MNCs. Our data suggest that osmotically induced ∆N-TRPV1 
translocation occurs in MNCs, and that the translocation is dependent on PLC𝛿1. Because PKC 
and SNARE-dependent exocytosis are both activated by PLC (Jeske et al., 2009; Zhang et al, 2005; 
Morenilla-Palao et al., 2004; Planells-Cases et al., 2011; Camprubí-Robles et al., 2009; Rhee, 
2001; Sakai et al., 2010), we suggest that PLC𝛿1 could modulate the intracellular processes that 
lead to osmotically induced ∆N-TRPV1 translocation. This novel finding is important to our 
understanding of MNC osmoregulation. As illustrated by our laboratory in a recent study (Park et 
al., 2021), PL𝛿1 KO mice exhibit dysfunctional systemic osmoregulation as well as the inability 
to transduce changes in external osmolality into the depolarizing currents that lead to enhanced 
MNC AP firing and VP release. PLC𝛿1 could be responsible for modulating sustained increases 
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in osmosensory transduction and ∆N-TRPV1 current through its apparent effects on ∆N-TRPV1 
translocation and MNC hypertrophy. These findings provide evidence for the physiological 
significance of PLC𝛿1 and its functions in osmoregulation. 
 
6.7 Integration of short- and long-term adaptations of MNCs to hyperosmolality 
 
6.7.1 Short-term processes mediated by PLC𝜹1 in response to hyperosmolality 
 
When isolated MNCs are exposed to a hyperosmotic solution, they shrink (Oliet and Bourque, 
1993). This shrinkage activates the mechanosensitive ∆N-TRPV1 channels and enables cation 
influx and depolarization of the MNC, therefore making it more likely to fire APs (Zaelzer et al., 
2015). This depolarization activates L-type Ca2+ channels and enables Ca2+ influx (Zaelzer et al., 
2015). We suggest that the increase in [Ca2+]i that results from the Ca2+ influx then leads to the 
activation of PLC𝛿1. Once activated, PLC𝛿1 cleaves PIP2 into IP3 and DAG (for more information 
on PLC activation, see section 1.3.1.1; Rhee, 2001). Modulating PIP2 levels can directly modulate 
TRPV1 activity in other neurons (Lukacs et al., 2007; Rohacs et al., 2008), so the increase in PIP2 
cleavage may also modulate ∆N-TRPV1 activity in MNCs. The PKC that is activated downstream 
by DAG could potentially phosphorylate ∆N-TRPV1 on the membrane and enhance their open 
probability, as has been shown in other neuron types (Premkumar and Ahern, 2000; Vellani et al., 
2001). PKC activation could also enhance F-actin polymerization and further enhance the 
mechanosensitivity of membrane-bound ∆N-TRPV1 channels (Zhang et al., 2007b; Zhang and 
Bourque, 2008). The model described in section 1.6 explains in further detail how we suggest 
PLC𝛿1 modulates short-term MNC osmoregulation. We suggest a new mechanism below for the 
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long-term structural and functional adaptations of MNCs that we also believe to be mediated by 
PLC𝛿1. 
 
6.7.2 Long-term responses of MNCs to hyperosmolality 
 
The more rapid changes in MNCs described above do not provide a full explanation for the ability 
of MNCs to sustain a high degree of AP firing and hormone output in response to sustained 
increases in osmolality. Because MNCs undergo structural and functional adaptations in response 
to sustained increases in external osmolality (e.g., from dehydration), such as hypertrophy (Miyata 
and Hatton, 2002; Shah et al., 2014), upregulation of genes (Ghorbel et al., 2003), and increased 
membrane density of channels and receptors (Shuster et al., 1999; Tanaka et al., 1999; Hurbin et 
al., 2002), there are likely multiple processes that contribute to the adaptive responses of MNCs to 
sustained hyperosmolar exposure. It is not yet known exactly how MNCs adapt to sustained high 
osmolality, but our recent findings suggest that osmotically induced ∆N-TRPV1 translocation may 
be one adaptive mechanism. We also suggest based on the data presented in Chapter 5 that PLC𝛿1 













Electrophysiology is a powerful tool that could be used to observe what happens to ∆N-TRPV1 
currents during sustained exposure to hyperosmolality. Based on the evidence presented in Chapter 
5, we predict that there would be an increase in ∆N-TRPV1 currents because the osmotically 
induced ∆N-TRPV1 translocation increases plasma membrane ∆N-TRPV1 density. We have 
begun to test this hypothesis, and preliminary data from our laboratory have shown that there is an 
increase in ∆N-TRPV1 conductance with sustained exposure to hyperosmolality (Dr. Sung Jin 
Park, unpublished data). The increase in conductance could be due to an increase in ∆N-TRPV1 
open probability. We have also performed immunocytochemistry and electrophysiology 
experiments to address this possibility and have found that after a 10-minute exposure to 
hyperosmolality, there is a significant increase in ∆N-TRPV1 conductance compared to cells that 
remained in isosmotic solution, but no significant increase in plasma membrane ∆N-TRPV1 
density (Dr. Sung Jin Park and Kirk Haan, unpublished data). The increase in ∆N-TRPV1 
conductance after 1 hour of exposure to hyperosmolality was significantly higher than the increase 
after 10 minutes. These data suggest that the initial increase in ∆N-TRPV1 conductance is due to 
an increase in open probability and not plasma membrane ∆N-TRPV1 density, but the sustained 
increase in ∆N-TRPV1 conductance is due to ∆N-TRPV1 translocation only. How ∆N-TRPV1 
mechanosensitivity is affected after the addition of membrane to the cell surface during the 




MNC hypertrophy could decrease the membrane stretch of MNCs. ∆N-TRPV1 on the MNC 
membrane could therefore become less active due to the mechanical gating nature of the channel 
(see section 1.2.5 for more information). During osmotically induced ∆N-TRPV1 translocation 
there is an increase in plasma membrane ∆N-TRPV1 density, which will increase conductance and 
depolarizing currents by itself. It is possible that during MNC hypertrophy, ∆N-TRPV1 current 
depends less on interactions with the cytoskeleton and more on other processes like translocation. 
∆N-TRPV1 currents during hypertrophy may also be influenced by phosphorylation by PKC. 
Previous studies have shown that TRPV1 phosphorylation by PKC enhances its open probability 
(Premkumar and Ahern, 2000; Vellani et al., 2001). We have shown above that osmotically 
induced ∆N-TRPV1 translocation depends on PLC𝛿1 and PKC activation, so enhanced PKC 
activation in response to the enhanced osmotic activation of PLC𝛿1 could enhance the 
phosphorylation and therefore open probability of ∆N-TRPV1, which could lead to the increase in 
∆N-TRPV1 current that we have observed. This explanation emphasizes the importance of 
translocation of ∆N-TRPV1 to the membrane, and the activation of PKC by PLC𝛿1 that could 
further enhance ∆N-TRPV1 currents and translocation of more ∆N-TRPV1 to the membrane. 
 
6.8.2 In vivo experimentation 
 
Since we have shown that osmotically induced ∆N-TRPV1 translocation occurs in vitro, a next 
step would be to examine how ∆N-TRPV1 translocation is important for osmoregulation in vivo. 
To explore this possibility, we could perform ∆N-TRPV1 immunocytochemistry and 
immunohistochemistry experiments on rats that have undergone a 24-hour period of dehydration, 
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as this period seemed to be sufficient to elicit a significant increase in blood osmolality in mice 
(Zerbe and Robertson, 1983; Zingg et al., 1986). We could use this period to examine how 
dehydration affects plasma membrane ∆N-TRPV1 density. We could also examine ∆N-TRPV1 
currents in MNCs isolated from dehydrated rats that are placed in hyperosmotic solution using 
electrophysiology to determine whether similar currents observed using hyperosmotic stimulation 
in vitro would be observed using MNCs from dehydrated rats. 
 
It would be of interest to attempt to block translocation in vivo by injecting inhibitors of 
translocation like Exo-1 and TAT-NSF700 (see section 3.3.4 and section 3.3.5 for more 
information on Exo-1 and TAT-NSF-700, respectively) into the SONs of rats that are being 
dehydrated and compare their blood osmolality to dehydrated rats injected with saline alone. From 
these experiments we could also examine MNC plasma membrane ∆N-TRPV1 density to observe 
whether administering a translocation inhibitor in vivo prevents osmotically induced ∆N-TRPV1 
translocation, and whether that could be correlated with a more pronounced increase in serum 
osmolality like that observed in dehydrated PLC𝛿1 KO mice (Park et al., 2021). Observing ∆N-
TRPV1 currents would also be of interest in MNCs isolated from dehydrated rats treated with Exo-
1 or TAT-NSF700 in vivo to observe whether the presence of the translocation inhibitor diminishes 
osmotically evoked ∆N-TRPV1 currents. 
 
It would also be of interest to determine the synaptotagmin isoform involved in osmotically 
induced ∆N-TRPV1 translocation (for more information on synaptotagmin and SNARE-mediated 
exocytosis, see section 1.4.1). Once we have identified the isoform, we could create an inducible 
KO model mouse for the synaptotagmin isoform to observe whether lacking the isoform elicits 
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any defects in systemic osmoregulation, MNC hypertrophy, or osmotically induced ∆N-TRPV1 
translocation. The inducibility of the KO would also allow us to examine whether knocking the 
synaptotagmin back into function restores any degree of normal osmoregulation. 
 
6.8.3 Transcription and translation in osmotically induced ∆N-TRPV1 translocation 
 
Because dehydration lasting periods of days leads to changes in gene expression in MNCs 
(Ghorbel et al., 2003; Shuster et al., 1999), it is possible that ∆N-TRPV1 transcription and 
translation are also upregulated in MNCs during dehydration. The synthesis and packaging of new 
∆N-TRPV1 into vesicles could potentially provide MNCs with a continual source of new ∆N-
TRPV1 vesicles that could then be translocated to the MNC plasma membrane in addition to the 
pre-existing vesicles that apparently translocate to the membrane under osmotic stress. Sp1 and 
Sp4 are transcription factors that mediate TRPV1 transcription in other neurons (Chu et al., 2011). 
Sp4 expression is required for the persistence of hyperalgesia (Sheehan et al., 2019), and 
hyperalgesia requires TRPV1 (Davis et al., 2000). Mice that are hemizygous (+/-) for Sp4 do not 
display persistent hyperalgesia or an increase in mechanical hypersensitivity by TRPV1 (Sheehan 
et al., 2019), suggesting an intrinsic relationship between Sp4 expression and the expression of 
TRPV1. Sp1 and Sp4 are nuclear proteins that are activated through phosphorylation by PKC (You 
et al., 2007; Tan and Khachigian, 2009) in a Ca2+-dependent manner (Chu et al., 2011). Sp1 and 
Sp4 are located on the GC box of the P2-promoter region of the TRPV1 gene (Chu et al., 2011), 
and once activated promote the transcription of TRPV1 mRNA (Chu et al., 2011) through RNA 
polymerase II activation (Dynan and Tjian, 1983). PKC has also been shown to enhance TRPV1 
translation in other neurons (Kays et al., 2018). There is potential for these processes to be present 
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in MNCs, though it has not yet been examined. Because the transcription, translation, and 
translocation of TRPV1 requires PKC and Ca2+ in other neurons (Chu et al., 2011; You et al., 
2007; Kays et al., 2018; Jeske et al., 2009; Zhang et al., 2005; Morenilla-Palao et al., 2004) and 
osmotically evoked hypertrophy requires PKC, Ca2+, and changes in gene expression in MNCs 
(Shah et al., 2014; Ghorbel et al., 2003), it is possible that osmotically induced ∆N-TRPV1 
transcription and translation could occur alongside osmotically induced ∆N-TRPV1 translocation 
in MNCs. If transcription and translation of new ∆N-TRPV1 channels plays a role in the long-term 
response of MNCs and coincides with ∆N-TRPV1 translocation, there is potential for PLC𝛿1 to 
also play a role in the synthesis of new ∆N-TRPV1. The osmotic stimulation of PLC𝛿1 that 
enhances PKC activity could influence the PKC-enabled transcription and translation of ∆N-
TRPV1 channels.   
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CHAPTER 7: CONCLUSIONS 
 
 
MNCs of the SON possess unique physiological adaptations to changes in external osmolality in 
vivo and in vitro. These physiological adaptations include changes in cell size, membrane channel 
and receptor density, protein expression, and electrical activity, some or all of which may 
contribute to the ability of MNCs to sustain a high degree of AP firing and hormone release under 
long-term hyperosmotic stress. We have shown a novel mechanism of reversible, osmotically 
induced ΔN-TRPV1 translocation to the MNC plasma membrane from internal stores in isolated 
MNCs, which also accompanies hypertrophy in response to sustained hyperosmolar exposure. We 
have also shown that the osmotically induced increase in plasma ΔN-TRPV1 levels requires the 
activation of both PLC and PKC, as well as SNARE-mediated exocytosis and vesicular transport 
from the Golgi. Furthermore, the reversal of the osmotically induced increase in plasma 
membrane ΔN-TRPV1 that occurs once a hyperosmotic stimulus is removed requires dynamin-
mediated endocytosis. Lastly, we have shown that mice that lack PLC𝛿1 do not possess the ability 
to increase MNC size or plasma membrane ΔN-TRPV1 levels in response to hyperosmolality, 
suggesting that it is the PLC isoform involved in mediating osmotically induced ΔN-TRPV1 
translocation and MNC hypertrophy. In the future, we would like to further examine the 
electrophysiological implications of ∆N-TRPV1 translocation (as outlined in section 6.8.1), as 
well as explore osmotically induced ΔN-TRPV1 translocation in vivo and the possibility of the 
involvement of transcription and translation in the process (as outlined in section 6.8.2 and section 
6.8.3, respectively). These findings further elucidate the mechanisms of MNC hypertrophy and 
osmoregulation in mammals and provide an explanation for the sustained AP firing of and 
hormone release from MNCs of water-deprived or dehydrated mammals.  
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